<article article-type="research-article" dtd-version="1.4" xml:lang="en" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">IUCrJ</journal-id><journal-id journal-id-type="iso-abbrev">IUCrJ</journal-id><journal-id journal-id-type="pmc-domain-id">2440</journal-id><journal-id journal-id-type="pmc-domain">iucrj</journal-id><journal-id journal-id-type="publisher-id">IUCrJ</journal-id><journal-title-group><journal-title>IUCrJ</journal-title></journal-title-group><issn pub-type="epub">2052-2525</issn><publisher><publisher-name>International Union of Crystallography</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12224078</article-id><article-id pub-id-type="pmcid-ver">PMC12224078.1</article-id><article-id pub-id-type="pmcaid">12224078</article-id><article-id pub-id-type="pmcaiid">12224078</article-id><article-id pub-id-type="pmid">40549150</article-id><article-id pub-id-type="doi">10.1107/S2052252525005123</article-id><article-id pub-id-type="publisher-id">lz5075</article-id><article-id pub-id-type="pii">S2052252525005123</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Papers</subject></subj-group></article-categories><title-group><article-title>Using multiple computer-predicted structures as molecular replacement models: application to the antiviral mini-protein LCB2</article-title><alt-title>Multiple computer-predicted structures as MR models</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Korban</surname><given-names initials="SA">Svetlana A.</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="b">b</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2993-6748</contrib-id><name name-style="western"><surname>Mikhailovskii</surname><given-names initials="O">Oleg</given-names></name><xref ref-type="aff" rid="c">c</xref><xref ref-type="author-notes" rid="aunote1">‡</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2730-6264</contrib-id><name name-style="western"><surname>Gurzhiy</surname><given-names initials="VV">Vladislav V.</given-names></name><xref ref-type="aff" rid="d">d</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5096-1278</contrib-id><name name-style="western"><surname>Podkorytov</surname><given-names initials="IS">Ivan S.</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7097-9192</contrib-id><name name-style="western"><surname>Skrynnikov</surname><given-names initials="NR">Nikolai R.</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="e">e</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><aff id="a"><label>a</label>Laboratory of Biomolecular NMR, <institution>St Petersburg State University</institution>, St Petersburg, 199034, <country country="RU">Russian Federation</country></aff><aff id="b"><label>b</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00n1nz186</institution-id></institution-wrap><institution>NRC Kurchatov Institute – PNPI</institution>
<addr-line content-type="city">Gatchina</addr-line>
<addr-line content-type="zipcode">188300</addr-line>
<country country="RU">Russian Federation</country></aff><aff id="c"><label>c</label>Utrecht, <country country="NL">The Netherlands</country></aff><aff id="d"><label>d</label>Crystallography Department, Institute of Earth Sciences, <institution>St Petersburg State University</institution>, St Petersburg, 199034, <country country="RU">Russian Federation</country></aff><aff id="e"><label>e</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dqehb95</institution-id></institution-wrap><institution content-type="dept">Department of Chemistry</institution>
<institution>Purdue University</institution>
<addr-line content-type="city">West Lafayette</addr-line>
<addr-line content-type="zipcode">IN 47907</addr-line>
<country country="US">USA</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Liu</surname><given-names initials="ZJ">Z.-J.</given-names></name><role>Editor</role></contrib><aff>Chinese Academy of Sciences, <country country="CN">China</country></aff></contrib-group><author-notes><corresp id="cor">Correspondence e-mail: <email>n.skrynnikov@spbu.ru</email></corresp><fn id="aunote1"><label>‡</label><p>Independent researcher.</p></fn></author-notes><pub-date pub-type="collection"><day>01</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>6</month><year>2025</year></pub-date><volume>12</volume><issue>Pt 4</issue><issue-id pub-id-type="pmc-issue-id">492167</issue-id><issue-id pub-id-type="publisher-id">m250400</issue-id><fpage>488</fpage><lpage>501</lpage><history><date date-type="received"><day>09</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>04</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>23</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-04 11:25:36.867"><day>04</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>© Svetlana A. Korban et al. 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref content-type="ccbylicense" specific-use="textmining">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.</license-p></license><ali:free_to_read/></permissions><self-uri content-type="pmc-pdf" xlink:href="m-12-00488.pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/><self-uri xlink:href="https://doi.org/10.1107/S2052252525005123" xmlns:xlink="http://www.w3.org/1999/xlink">A full version of this article is available from Crystallography Journals Online.</self-uri><abstract abstract-type="toc"><p>A set of crystallographic structures has been obtained for the small antiviral protein LCB2 using molecular replacement models from six different structure-prediction programs. This set of structures can be interpreted as a multiconformer ensemble, improving quality metrics and offering an interesting insight into side-chain dynamics.</p></abstract><abstract><p>In this report, we describe a set of structures of the engineered protein LCB2 that has been solved starting from different computer-predicted molecular replacement (MR) models. We found that <italic toggle="yes">AlphaFold3</italic>, <italic toggle="yes">AlphaFold2</italic>, <italic toggle="yes">MultiFOLD</italic>, <italic toggle="yes">Rosetta</italic>, <italic toggle="yes">RoseTTAFold</italic> and <italic toggle="yes">trRosetta</italic> all produced successful MR models for this three-helix bundle 58-residue protein, while some of the older predictors failed. To assign <italic toggle="yes">B</italic> factors in the MR models we used the predictor-generated confidence scores or, as a convenient alternative, the accessible surface area (ASA) values. The process of multi-start structure determination using <italic toggle="yes">Coot</italic> and <italic toggle="yes">Phenix</italic> demonstrated good convergence, leading to six structures within 0.25 Å (all-atom RMSD) of each other. Of note, structural differences between the computer-predicted MR models and the final structures can be largely attributed to a single specific crystal contact. Comparing the six structural solutions, we observe that a number of surface side chains have been solved with different conformations. Interestingly, for each individual structure the electron density is consistent with a single rotameric state and offers no direct evidence of conformational heterogeneity. Strictly speaking, this behavior constitutes a case of model bias; we argue, however, that it represents a benign side of model bias. Specifically, when we use a model where the side-chain conformation corresponds to one of the actual (significantly populated) rotameric states, this leads to an enhancement of the electron density for this particular conformation. Conversely, when we use a model with an irrelevant (low-population) side-chain conformation, it fails to produce the matching electron density. We thus conclude that the six LCB2 structures obtained in this study can be grouped into a multiconformer ensemble, where structural variations are representative of protein’s conformational dynamics. Indeed, using this six-member ensemble leads to a significant drop in <italic toggle="yes">R</italic><sub>work</sub> and <italic toggle="yes">R</italic><sub>free</sub> compared with the individual solutions. This interpretation was also supported by our MD simulations of the LCB2 crystal.</p></abstract><kwd-group><kwd>LCB2</kwd><kwd>molecular replacement</kwd><kwd>protein crystallography</kwd><kwd>computer-predicted structures</kwd><kwd>rotamers</kwd><kwd>side-chain conformations</kwd><kwd>multiconformer ensembles</kwd></kwd-group><funding-group><award-group id="ag1"><funding-source><institution-wrap><institution>Saint Petersburg State University</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry"/></institution-wrap></funding-source><award-id>AAAA-A16-116102010033-6</award-id><principal-award-recipient>Nikolai R. Skrynnikov</principal-award-recipient></award-group><award-group id="ag2"><funding-source><institution-wrap><institution>Russian Ministry of Science and Higher Education</institution><institution-id/></institution-wrap></funding-source><award-id>1023031500033-1-1.6.7</award-id></award-group><award-group id="ag3"><funding-source><institution-wrap><institution>Russian Ministry of Science and Higher Education</institution><institution-id/></institution-wrap></funding-source><award-id>1023031500033-1-1.6.4</award-id></award-group><award-group id="ag4"><funding-source><institution-wrap><institution>Russian Ministry of Science and Higher Education</institution><institution-id/></institution-wrap></funding-source><award-id>1023031500033-1-1.6.8</award-id></award-group><funding-statement>This work was supported by the grant 127400408 from Saint Petersburg State University. The purchase of the equipment for protein crystallization was funded by the Russian Ministry of Science and Higher Education through grants No. 1023031500033-1-1.6.7;1.6.4;1.6.8 awarded to the NRC Kurchatov Institute – PNPI.</funding-statement></funding-group><counts><page-count count="14"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1" sec-type="introduction"><label>1.</label><title>Introduction</title><p>At the present time, 74% of all crystallographic protein structures in the Protein Data Bank (PDB) have been solved using the molecular replacement (MR) technique. Traditionally, MR models have been obtained using crystallographic structures of homologous proteins. It has been customary to edit such homology models. The editing may involve partial or complete removal of side chains, as well as removal of loops that have low sequence similarity to the target or appear conformationally disordered (as deduced from consideration of multiple search models) (Evans &amp; McCoy, 2008<xref ref-type="bibr" rid="bb26"> ▸</xref>; Abergel, 2013<xref ref-type="bibr" rid="bb1"> ▸</xref>). More sophisticated search models have also been employed, such as ensemble models (Kleywegt &amp; Jones, 1996<xref ref-type="bibr" rid="bb38"> ▸</xref>) or models adjusted to account for domain dynamics in multidomain proteins (Suhre &amp; Sanejouand, 2004<xref ref-type="bibr" rid="bb79"> ▸</xref>).</p><p>Over time, crystallographers started using specialized modeling programs to improve on homology templates. The first such example in the PDB was <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1qnw" xmlns:xlink="http://www.w3.org/1999/xlink">1qnw</ext-link> (Loris <italic toggle="yes">et al.</italic>, 2000<xref ref-type="bibr" rid="bb46"> ▸</xref>), which was solved with the help of the homology modeling tool <italic toggle="yes">SWISS-MODEL</italic> (Guex &amp; Peitsch, 1997<xref ref-type="bibr" rid="bb27"> ▸</xref>). Soon thereafter the structure <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1qym" xmlns:xlink="http://www.w3.org/1999/xlink">1qym</ext-link> was reported (Manjasetty <italic toggle="yes">et al.</italic>, 2004<xref ref-type="bibr" rid="bb51"> ▸</xref>), where the MR model was based not on a single homology template, but rather on several templates automatically selected by <italic toggle="yes">SWISS-MODEL</italic>. At about the same time the structure <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1row" xmlns:xlink="http://www.w3.org/1999/xlink">1row</ext-link> (Schormann <italic toggle="yes">et al.</italic>, 2004<xref ref-type="bibr" rid="bb76"> ▸</xref>) was solved using the homology template prepared by<italic toggle="yes"> MODELLER</italic> (Šali &amp; Blundell, 1993<xref ref-type="bibr" rid="bb75"> ▸</xref>). The option of using <italic toggle="yes">MODELLER</italic> to improve on homology templates has also been offered by the CaspR server (Claude <italic toggle="yes">et al.</italic>, 2004<xref ref-type="bibr" rid="bb18"> ▸</xref>).</p><p>It should be noted, however, that initially the attempts to use modeling programs to improve on homology templates met with only very limited success. Special tests to investigate this matter have been conducted as a part of the biannual Critical Assessment of Structure Prediction (CASP) competition. The first such test under the ‘model refinement’ category showed that only a small fraction of all treated templates were actually improved, and even then the improvement was mostly marginal (MacCallum <italic toggle="yes">et al.</italic>, 2009<xref ref-type="bibr" rid="bb50"> ▸</xref>). Over the next decade there was some progress in this area, but the results still left much to be desired (Read <italic toggle="yes">et al.</italic>, 2019<xref ref-type="bibr" rid="bb72"> ▸</xref>). Because of the recent successes in <italic toggle="yes">ab initio</italic> structure predictions (see below), this CASP category has been discontinued (Millán <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb58"> ▸</xref>).</p><p>While homology-based predictors rely on the information from a limited number of homologous structures, <italic toggle="yes">ab initio</italic> predictors (also known as <italic toggle="yes">de novo</italic> predictors) make use of a generalized knowledge of the principles of protein architecture that is derived from a large body of structural data, such as the entire PDB repository. It should be noted that the boundary between homology-based and <italic toggle="yes">ab initio</italic> predictors is blurred: many predictors that have their roots in homology modeling have evolved into more general instruments utilizing large amounts of structural information. One of the early leaders in the field of <italic toggle="yes">ab initio</italic> structure prediction was <italic toggle="yes">Rosetta</italic>; over time this program has gone through a number of transformative changes (Das &amp; Baker, 2008<xref ref-type="bibr" rid="bb21"> ▸</xref>; Yang <italic toggle="yes">et al.</italic>, 2020<xref ref-type="bibr" rid="bb90"> ▸</xref>; Watson <italic toggle="yes">et al.</italic>, 2023<xref ref-type="bibr" rid="bb88"> ▸</xref>). Using <italic toggle="yes">Rosetta</italic>, Baker and co-workers first demonstrated that an <italic toggle="yes">ab initio</italic> protein model can successfully be used as an MR model (Qian <italic toggle="yes">et al.</italic>, 2007<xref ref-type="bibr" rid="bb66"> ▸</xref>). A number of studies followed, where <italic toggle="yes">ab initio</italic> MR models were tested for dozens and even hundreds of crystallographic datasets (Rigden <italic toggle="yes">et al.</italic>, 2008<xref ref-type="bibr" rid="bb74"> ▸</xref>; Das &amp; Baker, 2009<xref ref-type="bibr" rid="bb22"> ▸</xref>; Rämisch <italic toggle="yes">et al.</italic>, 2015<xref ref-type="bibr" rid="bb68"> ▸</xref>); a special platform, <italic toggle="yes">AMPLE</italic>, was developed to support such applications (Bibby <italic toggle="yes">et al.</italic>, 2012<xref ref-type="bibr" rid="bb7"> ▸</xref>; Keegan <italic toggle="yes">et al.</italic>, 2015<xref ref-type="bibr" rid="bb35"> ▸</xref>; Simpkin <italic toggle="yes">et al.</italic>, 2019<xref ref-type="bibr" rid="bb77"> ▸</xref>). New crystallographic structures solved with the help of <italic toggle="yes">Rosetta</italic>-generated <italic toggle="yes">ab initio</italic> MR models started to emerge as well (Sun <italic toggle="yes">et al.</italic>, 2018<xref ref-type="bibr" rid="bb80"> ▸</xref>; Takekawa <italic toggle="yes">et al.</italic>, 2019<xref ref-type="bibr" rid="bb81"> ▸</xref>).</p><p>Three years ago, the highly accurate neural-network-based predictor <italic toggle="yes">AlphaFold2</italic> took the field by storm (Jumper <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb34"> ▸</xref>). Tests have shown that <italic toggle="yes">AlphaFold2</italic> can generate MR models with a success rate of <italic toggle="yes">ca</italic> 90% (Millán <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb58"> ▸</xref>; McCoy <italic toggle="yes">et al.</italic>, 2022<xref ref-type="bibr" rid="bb55"> ▸</xref>; Pereira <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb65"> ▸</xref>; Terwilliger <italic toggle="yes">et al.</italic>, 2023<xref ref-type="bibr" rid="bb82"> ▸</xref>). Two very recent studies found that as many as 92% of the structures that were originally determined using single-wavelength anomalous diffraction can successfully be solved by means of the (appropriately edited) MR models by <italic toggle="yes">AlphaFold2</italic> (Keegan <italic toggle="yes">et al.</italic>, 2024<xref ref-type="bibr" rid="bb36"> ▸</xref>; Wang <italic toggle="yes">et al.</italic>, 2025<xref ref-type="bibr" rid="bb87"> ▸</xref>). Taking advantage of this new opportunity, a number of structures have been solved using diffraction datasets that defied previous structure-solving efforts (Kryshtafovych <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb39"> ▸</xref>; Barbarin-Bocahu &amp; Graille, 2022<xref ref-type="bibr" rid="bb6"> ▸</xref>). Not surprisingly, the number of structures determined with the help of MR models from <italic toggle="yes">AlphaFold2</italic> has grown dramatically in recent years. By early summer 2023, the PDB contained 224 identifiable structures that have been solved in this manner. Only a year later we found 911 such structures. As of this day the number has reached 2142 (this includes the structures solved with the help of <italic toggle="yes">AlphaFold3</italic>). The actual number is probably even higher because some depositors indicate that MR models have been generated <italic toggle="yes">in silico</italic> without providing any further details.</p><p>Other programs strive to replicate this success. In particular, <italic toggle="yes">RoseTTAFold</italic> has similar capabilities to <italic toggle="yes">AlphaFold2</italic> and also led to a number of <italic toggle="yes">de novo</italic> protein structures (Baek <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb4"> ▸</xref>). New technologies have also been incorporated into the recently released <italic toggle="yes">D-I-TASSER</italic> and <italic toggle="yes">D-QUARK</italic> servers (Zheng <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb91"> ▸</xref>; Zheng <italic toggle="yes">et al.</italic>, 2023<xref ref-type="bibr" rid="bb92"> ▸</xref>). <italic toggle="yes">ESMFold</italic> employs an algorithm which is nearly as accurate as <italic toggle="yes">AlphaFold2</italic>, but computationally is much faster (Lin <italic toggle="yes">et al.</italic>, 2023<xref ref-type="bibr" rid="bb44"> ▸</xref>). <italic toggle="yes">MultiFOLD</italic> and its companion programs bring to the table the ability to model protein assemblies (McGuffin <italic toggle="yes">et al.</italic>, 2023<xref ref-type="bibr" rid="bb56"> ▸</xref>). Finally, the arrival of <italic toggle="yes">AlphaFold3</italic> sets a new benchmark in this rapidly progressing field (Abramson <italic toggle="yes">et al.</italic>, 2024<xref ref-type="bibr" rid="bb2"> ▸</xref>). Methodological studies in the area of protein structure prediction also continue at a rapid pace (Huang <italic toggle="yes">et al.</italic>, 2023<xref ref-type="bibr" rid="bb30"> ▸</xref>).</p><p>In this communication we take an approach that is somewhat different from most tests of computer-generated MR models. Specifically, instead of testing a single predictor across a set of crystallographic structures, we have tested a number of predictors on a single structure. The structure is that of a small (58 residues) engineered protein, LCB2, which was developed in Baker’s laboratory as a blocking ligand of the SARS-CoV-2 spike protein (Cao <italic toggle="yes">et al.</italic>, 2020<xref ref-type="bibr" rid="bb14"> ▸</xref>). It was envisioned that solutions of mini-proteins such as LCB2 could be used in the form of a nasal spray to confer temporary protection against the coronavirus infection. Two of the higher-affinity mini-proteins, LCB1 and AHB2, saw further development, proving their effectiveness in animal models (Case <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb16"> ▸</xref>; Hunt <italic toggle="yes">et al.</italic>, 2022<xref ref-type="bibr" rid="bb31"> ▸</xref>). While LCB2 was validated by means of biolayer interferometry experiments and tested in cell culture assays employing live virus, it has not been developed further.</p><p>We have found that the original design model of LCB2 (in complex with the receptor-binding domain of the viral spike protein) (Cao <italic toggle="yes">et al.</italic>, 2020<xref ref-type="bibr" rid="bb14"> ▸</xref>) offers a <italic toggle="yes">bona fide</italic> MR model to solve the crystallographic structure. This is not surprising since there is a fairly long history of <italic toggle="yes">Rosetta</italic> design models being successfully used as MR models in crystallographic studies (Chen <italic toggle="yes">et al.</italic>, 2019<xref ref-type="bibr" rid="bb17"> ▸</xref>; Boyken <italic toggle="yes">et al.</italic>, 2019<xref ref-type="bibr" rid="bb8"> ▸</xref>). Furthermore, all-helical proteins, such as LCB2, are known to be best suited for this type of application (Bibby <italic toggle="yes">et al.</italic>, 2012<xref ref-type="bibr" rid="bb7"> ▸</xref>). In addition, we have also obtained successful MR models from <italic toggle="yes">AlphaFold3</italic>, <italic toggle="yes">AlphaFold2</italic>, <italic toggle="yes">MultiFOLD</italic>, <italic toggle="yes">RoseTTAFold</italic> and <italic toggle="yes">trRosetta</italic> (Du <italic toggle="yes">et al.</italic>, 2021<xref ref-type="bibr" rid="bb24"> ▸</xref>). A few other predictors did not reach the level of accuracy that is required of an MR model.</p><p>We performed the process of structure determination beginning with each of the six productive computer-predicted MR models. For each starting model the procedure was performed independently using the standard iterative protocol involving <italic toggle="yes">Coot</italic> (Emsley <italic toggle="yes">et al.</italic>, 2010<xref ref-type="bibr" rid="bb25"> ▸</xref>) and <italic toggle="yes">Phenix</italic> (Liebschner <italic toggle="yes">et al.</italic>, 2019<xref ref-type="bibr" rid="bb41"> ▸</xref>). While the initial models showed appreciable variability (up to 0.87 Å) and differed substantially from the final coordinates (up to 1.08 Å), the structure determination process fully converged, resulting in six refined models within 0.25 Å from each other. This kind of precision can be expected for a diffraction dataset with 2.1 Å resolution, as acquired in our study.</p><p>The idea of screening of multiple candidate MR models (search models) is well established in protein crystallography (Keegan &amp; Winn, 2007<xref ref-type="bibr" rid="bb37"> ▸</xref>; Stokes-Rees &amp; Sliz, 2010<xref ref-type="bibr" rid="bb78"> ▸</xref>). The purpose of such a screening procedure is normally to discover one usable MR model leading to the unique correct solution. In this study we adopted a somewhat different perspective. We employed six productive MR models to arrive at an ensemble of six distinct final structures, which are very similar yet not identical. It turns out that the differences are not limited to small atom displacements – some of the differences are more significant. In particular, a number of surface side chains were solved with different conformations.</p><p>Interestingly, for each of the individual structures the electron density for a given side chain is consistent with a single rotameric state – and offers no evidence (or little evidence) of conformational heterogeneity. However, when we compare the structures obtained from different MR models, we observe the presence of multiple side-chain conformations. Strictly speaking, this is an example of model bias whereby the final solution is dependent on a prior model. The biased character of the solutions (in terms of the side-chain conformations for several specific residues) was confirmed by inspection of the OMIT maps (Liebschner <italic toggle="yes">et al.</italic>, 2017<xref ref-type="bibr" rid="bb42"> ▸</xref>).</p><p>Traditionally, model bias is considered to be a crystallographer’s enemy (Hodel <italic toggle="yes">et al.</italic>, 1992<xref ref-type="bibr" rid="bb28"> ▸</xref>). However, here we argue that model bias can also be a crystallographer’s friend. Specifically, when we use a model where the side-chain conformation corresponds to one of the rotameric states that is significantly populated in the actual crystal, we thereby ‘tease out’ the electron density for this particular conformation. When we use several relevant models, we therefore recover the conformational ensemble of the side chain in question. Indeed, treating the collection of six LCB2 structures as a multiconformer ensemble, we observe a significant drop in <italic toggle="yes">R</italic><sub>work</sub> and <italic toggle="yes">R</italic><sub>free</sub> values compared with the individual structures. The conformational disorder at the sites of interest was also confirmed by a series of crystal MD simulations.</p></sec><sec id="sec2" sec-type="materials|methods"><label>2.</label><title>Materials and methods</title><p>Details of LCB2 expression and purification, functional assay using isothermal titration calorimetry, protein crystallization, diffraction data collection and processing, principal component analyses and MD modeling are provided as a part of the supporting information.</p><sec id="sec2.1"><label>2.1.</label><title>MR models</title><p><italic toggle="yes">AlphaFold3</italic>. The web server <ext-link ext-link-type="uri" xlink:href="https://www.alphafoldserver.com" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.alphafoldserver.com</ext-link> was used to generate <italic toggle="yes">ab initio</italic> models of LCB2 (web addresses of structure-prediction servers employed in this study are summarized in Table S3). Five models were manufactured, which is the default output for this server. The protein sequence was the same as employed in our crystallographic study (see the supporting information). Note that <italic toggle="yes">AlphaFold3</italic> was trained on the PDB structures released before 30 September 2021 and therefore has not seen our crystallographic structure <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link>. The models, which do not include hydrogen atoms, contain predicted local distance difference test (pLDDT) scores (Mariani <italic toggle="yes">et al.</italic>, 2013<xref ref-type="bibr" rid="bb52"> ▸</xref>) placed in the field that is normally reserved for <italic toggle="yes">B</italic> factors. To further process the models, we have used three different protocols:</p><p>(i) Conversion of pLDDT scores to <italic toggle="yes">B</italic> factors using <italic toggle="yes">phenix.process_predicted_model</italic> (Oeffner <italic toggle="yes">et al.</italic>, 2022<xref ref-type="bibr" rid="bb61"> ▸</xref>); in doing so, several atoms with lower confidence scores, pLDDT &lt; 70, were deleted according to the default setting ‘remove low-confidence residues’: Ser2 O<sup>γ</sup>, Lys29 N<sup>ζ</sup>, Arg41 N<sup>η1</sup> and Arg41 N<sup>η2</sup>, Arg49 N<sup>η1</sup> and Arg49 N<sup>η2</sup>, Arg52 N<sup>η1</sup> and Lys56 N<sup>ζ</sup>.</p><p>(ii) Generation of <italic toggle="yes">B</italic> factors based on the degree of solvent exposure of the individual atoms in the model using <italic toggle="yes">phenix.sculptor</italic> (Bunkóczi &amp; Read, 2011<italic toggle="yes">b</italic><xref ref-type="bibr" rid="bb11"> ▸</xref>).</p><p>(iii) Assignment of the same constant value to all atomic <italic toggle="yes">B</italic> factors using <italic toggle="yes">phenix.sculptor</italic> (<italic toggle="yes">e.g.</italic> 10 or 20, the specific value does not matter for the subsequent <italic toggle="yes">phenix.phaser</italic> treatment).</p><p>In this manner, we produced 15 starting models, which differed from each other by atomic coordinates and/or <italic toggle="yes">B</italic>-factor values. All of these models were processed by <italic toggle="yes">phenix.phaser</italic> (McCoy <italic toggle="yes">et al.</italic>, 2007<xref ref-type="bibr" rid="bb54"> ▸</xref>). In doing so, we indicated that the expected number of protein molecules in the asymmetric unit was 2 (although in reality there is only 1 protein molecule per asymmetric unit). This proved to be a helpful initial guess because it effectively accounts for the presence of <italic toggle="yes">ca</italic> 50% twinning in our crystal and thus provides the program with a better initial estimate of the σ<sub><italic toggle="yes">A</italic></sub> function (McCoy, 2017<xref ref-type="bibr" rid="bb53"> ▸</xref>). Starting with this estimate, <italic toggle="yes">phenix.phaser</italic> consistently arrived at superior solutions characterized by higher log-likelihood gain (LLG) scores and translation function Z-scores (TFZ scores). Appropriately, these solutions featured a single protein molecule in the asymmetric unit. The complete list of 15 <italic toggle="yes">AlphaFold3</italic>-derived models with their respective LLG and TFZ scores is given in Table S4. From this list we selected the model with the highest scores, see Table 1<xref ref-type="table" rid="table1"> ▸</xref>, and used it as a starting point to solve the structure via the standard <italic toggle="yes">Phenix</italic>- and <italic toggle="yes">Coot</italic>-based procedure.</p><p><italic toggle="yes">AlphaFold2</italic>. <italic toggle="yes">AlphaFold2</italic> version 2.3.2 was accessed through the official Colab Notebook, see Table S3. A single <italic toggle="yes">ab initio</italic> model of LCB2 was generated, which is the default output for this server. The model originally included hydrogen atoms, which were deleted prior to <italic toggle="yes">phenix.phaser</italic> treatment. Using three different protocols to assign <italic toggle="yes">B</italic> factors, we arrived at three MR models containing residues 1 to 58 and a full complement of atoms. The best of these models, see Table 1<xref ref-type="table" rid="table1"> ▸</xref>, was used to solve the structure of LCB2. In this particular case, the process of the structure determination was performed twice, resulting in a pair of very similar, but not identical, structures.</p><p><italic toggle="yes">MultiFOLD</italic>. Five <italic toggle="yes">ab initio</italic> models of LCB2 were generated using the designated web server, see Table S3. The models originally included hydrogen atoms, which were deleted prior to <italic toggle="yes">phenix.phaser</italic> treatment. When processing the models with <italic toggle="yes">phenix.process_predicted_model</italic>, two N-terminal residues (Gly–Ser) were deleted according to the default setting ‘remove low-confidence residues’.</p><p><italic toggle="yes">Rosetta</italic>. The <italic toggle="yes">Rosetta</italic> model was from the archive included in the supporting information of the paper by Cao <italic toggle="yes">et al.</italic> (2020<xref ref-type="bibr" rid="bb14"> ▸</xref>). The model is a complex of the receptor-binding domain of the SARS-CoV-2 spike protein with LCB2 (whose original sequence does not include the N-terminal Gly–Ser residues). All <italic toggle="yes">B</italic> factors were originally assigned zero values. Prior to processing with <italic toggle="yes">phenix.phaser</italic>, the spike protein was removed from the model and the hydrogen atoms were deleted. Since pLDDT scores were not available for this particular Rosetta model, the <italic toggle="yes">B</italic> factors were either calculated based on accessible surface, option (ii), or all assigned the same constant value, option (iii). The better of the two resulting models was chosen for the role of the MR model.</p><p><italic toggle="yes">RoseTTAFold</italic>. Five <italic toggle="yes">ab initio</italic> models of LCB2 were generated using the designated web server, see Table S3. The models included estimated uncertainties (root-mean-square deviations) of the atomic coordinates, calculated internally by <italic toggle="yes">RoseTTAFold</italic> based on pLDDT scores (Oeffner <italic toggle="yes">et al.</italic>, 2022<xref ref-type="bibr" rid="bb61"> ▸</xref>). These values were converted to <italic toggle="yes">B</italic> factors using the relevant option in the program <italic toggle="yes">phenix.process_predicted_model</italic>. The same program also deleted four N-terminal residues (Gly–Ser–Ser–Asp) and one C-terminal residue (Leu), which were classified as low-confidence regions, RMSD &gt; 1.5 Å. Out of 15 distinct models with different atomic coordinates and/or <italic toggle="yes">B</italic> factors, the best one was used for <italic toggle="yes">Coot</italic>- and <italic toggle="yes">Phenix</italic>-assisted structure determination.</p><p><italic toggle="yes">trRosetta</italic>. Five <italic toggle="yes">ab initio</italic> models of LCB2 were generated using the designated web server, see Table S3. The models were missing all arginine N<sup>η1</sup> and N<sup>η2</sup> atoms as well as tyrosine O<sup>η</sup> atoms, and were used as such without any attempts to rebuild these atoms. <italic toggle="yes">B</italic> factors were assigned using options (i), (ii) and (iii), resulting in 15 distinct models, of which one model with the highest LLG and TFZ scores was chosen for further structure determination.</p><p>Similar schemes were also used for the <italic toggle="yes">QUARK</italic>, <italic toggle="yes">Phyre2</italic>, <italic toggle="yes">I-TASSER</italic> and <italic toggle="yes">SWISS-MODEL</italic> predictors. None of these methods led to productive MR models; therefore, we do not provide any further details on these efforts. The more recently released versions <italic toggle="yes">D-I-TASSER</italic> and <italic toggle="yes">D-QUARK</italic> were unsuit­able for the purpose of this study because these programs are familiar with our crystallographic structure <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link>. We also tested the recent predictor <italic toggle="yes">ESMFold</italic>, but found that its predicted model was very similar to the one generated by <italic toggle="yes">MultiFOLD</italic>; therefore we did not include it in subsequent analyses.</p><p>The refinement statistics shown in this paper are from <italic toggle="yes">phenix.refine</italic> (Afonine <italic toggle="yes">et al.</italic>, 2012<xref ref-type="bibr" rid="bb3"> ▸</xref>). In the case of ensemble interpretation, <italic toggle="yes">phenix.refine</italic>-reported model structure factors from the six final structures of LCB2 were averaged prior to calculation of <italic toggle="yes">R</italic><sub>work</sub> and <italic toggle="yes">R</italic><sub>free</sub>. In order to compare different MR models with each other and with the final structures, we defined the set of atoms shared by all of these models (structures). This ‘consensus set’ includes residues from 5 to 57, leaving out all N<sup>η1</sup> and N<sup>η2</sup> arginine atoms and all O<sup>η</sup> tyrosine atoms, as well as N<sup>ζ</sup> atoms from residues Lys29 and Lys56. All structural superpositions were generated using the final structure derived from the <italic toggle="yes">AlphaFold3</italic> model as a reference.</p></sec></sec><sec id="sec3" sec-type="results"><label>3.</label><title>Results</title><sec id="sec3.1"><label>3.1.</label><title>Structure overview</title><p>Table 1<xref ref-type="table" rid="table1"> ▸</xref> summarizes the information about the computer-predicted models that were tested as potential MR models to solve the crystallographic structure of LCB2. As detailed in <italic toggle="yes">Materials and methods</italic><xref ref-type="sec" rid="sec2"/>, almost all predictors generate multiple models (typically, five models) in response to a service request involving the amino-acid sequence of a target protein. For all these models, we used three different methods of assigning atomic <italic toggle="yes">B</italic> factors: based on accessible surface area (ASA) values, based on pLDDT scores (where the atoms with particularly poor scores were removed) or using a single constant value. All of the obtained variants were assessed by means of <italic toggle="yes">phenix.phaser</italic>, and one best model for each predictor was selected for further analyses. As usual, we have used LLG and TFZ scores as quality metrics (Read &amp; McCoy, 2016<xref ref-type="bibr" rid="bb71"> ▸</xref>; Bunkóczi <italic toggle="yes">et al.</italic>, 2013<xref ref-type="bibr" rid="bb9"> ▸</xref>). A complete summary of the <italic toggle="yes">phenix.phaser</italic> trials is given in Table S4, whereas the best models for all predictors are listed in Table 1<xref ref-type="table" rid="table1"> ▸</xref>.</p><p>One lesson that we learned from this exercise is that ASA-based assignment of <italic toggle="yes">B</italic> factors and pLDDT-based assignment of <italic toggle="yes">B</italic> factors lead to comparable results, whereas using uniform <italic toggle="yes">B</italic> factors is clearly less efficient (see Table S4). This means that pLDDT scores are not necessary to prepare a state-of-the-art MR model, since the long-known ASA-based approach provides a convenient alternative.</p><p>Inspection of LLG and TFZ scores in Table 1<xref ref-type="table" rid="table1"> ▸</xref> immediately suggests that six predictors have produced successful MR models: <italic toggle="yes">AlphaFold3</italic>, <italic toggle="yes">AlphaFold2</italic>, <italic toggle="yes">MultiFOLD</italic>, <italic toggle="yes">Rosetta</italic>, <italic toggle="yes">RoseTTAFold</italic> and <italic toggle="yes">trRosetta</italic>. At the same time, four of the older programs, <italic toggle="yes">QUARK</italic>, <italic toggle="yes">Phyre2</italic>, <italic toggle="yes">I-TASSER</italic> and <italic toggle="yes">SWISS-MODEL</italic>, apparently fell short (with a typical TFZ score of 5, these models are unlikely to produce a viable solution). Indeed, our efforts to solve a structure were successful with the former six MR models, but unsuccessful with the latter four.</p><p>In addition to the single best <italic toggle="yes">AlphaFold3</italic> model (LLG = 213, TFZ = 16), we also considered an ensemble comprised of five <italic toggle="yes">AlphaFold3</italic> models. In our tests using <italic toggle="yes">phenix.ensembler</italic> and <italic toggle="yes">phenix.phaser</italic>, this ensemble produced somewhat improved scores (LLG = 227, TFZ = 17). Apparently, the set of models generated by <italic toggle="yes">AlphaFold3</italic> to some degree captures the conformational variability of LCB2 (Bunkóczi &amp; Read, 2011<italic toggle="yes">a</italic><xref ref-type="bibr" rid="bb10"> ▸</xref>). One may expect that in certain borderline situations use of the computer-predicted ensembles (subject to trimming as needed) may tip the scales, leading to successful structure determination.</p><p>Turning to the usage statistics for computer-predicted MR models (the fourth column in Table 1<xref ref-type="table" rid="table1"> ▸</xref>), we observe that <italic toggle="yes">AlphaFold2</italic> followed by <italic toggle="yes">AlphaFold3</italic> have enjoyed great success as sources of workable MR models. Our results suggest, however, that other predictors, both preceding <italic toggle="yes">AlphaFold2</italic> (<italic toggle="yes">e.g.</italic><italic toggle="yes">Rosetta</italic>) and building on <italic toggle="yes">AlphaFold2</italic> technology (<italic toggle="yes">e.g.</italic><italic toggle="yes">MultiFOLD</italic>), can also produce <italic toggle="yes">bona fide</italic> MR models. This situation creates an opportunity for comparative analyses of LCB2 structures derived from different computer-predicted MR models.</p><p>Listed in Table 2<xref ref-type="table" rid="table2"> ▸</xref> are the refinement statistics for LCB2 structures obtained from the MR models by six different predictors. The structures are characterized by <italic toggle="yes">R</italic><sub>work</sub> of 0.21 and <italic toggle="yes">R</italic><sub>free</sub> of 0.24–0.25, typical of a crystallographic resolution of 2.10 Å. Local geometry measures, such as Ramachandran and rotamer outliers, clash scores and other metrics that are conveniently summarized in the <italic toggle="yes">MolProbity</italic> scores (Williams <italic toggle="yes">et al.</italic>, 2018<xref ref-type="bibr" rid="bb89"> ▸</xref>), are very good, reflecting the high quality of the automated refinement using <italic toggle="yes">phenix.refine</italic> (Afonine <italic toggle="yes">et al.</italic>, 2012<xref ref-type="bibr" rid="bb3"> ▸</xref>). All structures include residues from 4 to 58, with no alternative conformations; they also include from 1 to 4 glycerol molecules and between 18 and 24 water molecules. Based on these standard statistics it is hardly possible to rank the structures and identify the best (most accurate) set of coordinates. Instead, we argue that all of the structures are equally valid and one cannot be chosen over the other (as discussed further in this paper).</p><p>Shown in Figs. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">a</italic>)–1(<italic toggle="yes">f</italic>) are pairwise superpositions of the initial computer-predicted MR models and their descendant crystallographic structures. In all of these pairs we observe distinct differences in the conformation of the short loop connecting the second and third helices (residues 42–44). In addition, we observe that in the <italic toggle="yes">RoseTTAFold</italic> and <italic toggle="yes">trRosetta</italic> model the third helix is significantly shifted from its true (<italic toggle="yes">i.e.</italic> experimentally determined) position. The shift amounts to <italic toggle="yes">ca</italic> 2 Å in the case of the <italic toggle="yes">RoseTTAFold</italic> model and a little less than that for the <italic toggle="yes">trRosetta</italic> model, see Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">e</italic>) and Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">f</italic>).</p><p>The situation with the loop 42–44 led us to suggest that its conformation in the crystallographic structure is influenced by a crystal contact. Indeed, it turns out that residue Asn43 at the center of the loop forms an intermolecular side-chain-to-backbone hydrogen bond with the amide group of residue Glu46 in the symmetry-related protein molecule. This hydrogen bond apparently leads to stretching out of the loop (Rapp &amp; Pollack, 2005<xref ref-type="bibr" rid="bb69"> ▸</xref>), thus causing the difference between the computer-generated model and the actual structure, see Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">g</italic>). Apparently, we see an example of the situation where both the computer-predicted MR model and its related crystallographic structure are correct – yet they differ from each other because computer-prediction algorithms are agnostic of crystal contacts, whereas the experimental structures are (to some degree) sensitive to crystal contacts.</p><p>While the MR models show some differences from the final structures, the latter are characterized by near-identical backbone folds. The bundle in Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">h</italic>) shows a superposition of six structures colored according to the MR models that were used to solve these structures. All structures superimpose almost perfectly, with slight deviations observed only at the N-terminal residues 4–5. This picture indicates that the process of structure determination is well converged and, in a global sense, the final structures are free from any significant model bias.</p><p>Although the six final structures are nearly identical with respect to their backbone folds, the side chains are not as well defined. Shown in Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">i</italic>) is the bundle of six superimposed final structures, where the focus is on the side chains. While the majority of side chains are nicely reproduced across the entire set of structures, some others have been solved in different conformations. The origins of these differences are discussed later in this paper.</p><p>The differences between the initial MR models and the final structures can be conveniently quantified via pairwise root-mean-square deviation (RMSD) of the atomic coordinates. The RMSD values for all non-hydrogen atoms are summarized in the form of a heat map in Fig. 2<xref ref-type="fig" rid="fig2"> ▸</xref>. Considering the initial models (upper left quadrant in Fig. 2<xref ref-type="fig" rid="fig2"> ▸</xref>), we observe that some of the models are quite similar to each other, <italic toggle="yes">e.g.</italic> the <italic toggle="yes">AlphaFold2</italic> and <italic toggle="yes">MultiFOLD</italic> models are within 0.18 Å of each other, which reflects the genetic connection between the two programs. On the other hand, the <italic toggle="yes">RoseTTAFold</italic> and <italic toggle="yes">trRosetta</italic> models form a sort of cluster, which is appreciably different from the remaining four models, with RMSD values up to 0.87 Å. This is obviously related to the shift in the relative position of the helices, as visualized in Figs. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">a</italic>)–1(<italic toggle="yes">f</italic>).</p><p>At the same time, the MR models are visibly different from the final structures (<italic toggle="yes">cf</italic>. the upper right quadrant or, equivalently, lower left quadrant in Fig. 2<xref ref-type="fig" rid="fig2"> ▸</xref>). For the <italic toggle="yes">AlphaFold3</italic>, <italic toggle="yes">AlphaFold2</italic>, <italic toggle="yes">MultiFOLD</italic> and <italic toggle="yes">Rosetta</italic> models, this difference amounts to <italic toggle="yes">ca</italic> 0.7 Å. This deviation is in part attributable to the conformation of the loop 42–44, see Figs. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">a</italic>)–1(<italic toggle="yes">f</italic>). For the <italic toggle="yes">trRosetta</italic> and especially <italic toggle="yes">RoseTTAFold</italic> models the deviations are larger, up to 1.08 Å, due to the shift in the relative positions of the α-helices. In general terms, however, deviations on the scale of 1.08 Å or less are considered to be modest and correspond to high-quality MR models (Oeffner <italic toggle="yes">et al.</italic>, 2013<xref ref-type="bibr" rid="bb60"> ▸</xref>). This is consistent with our initial assessment of the MR models using LLG and TFZ scores and is ultimately confirmed by the success of the structure determination procedure.</p><p>Importantly, all of the final structures are nearly identical, with all-atom RMSDs in the range 0.10–0.25 Å (lower right quadrant in Fig. 2<xref ref-type="fig" rid="fig2"> ▸</xref>). These numbers provide a measure of uncertainty for the LCB2 coordinates, <italic toggle="yes">i.e.</italic> characterize the precision of the structure obtained here at 2.1 Å resolution. How does this precision compare with what is reported in the literature or found in the PDB? Historically, there has been some conflicting evidence regarding the convergence of X-ray structure determination and precision of crystallographic protein structures (Daopin <italic toggle="yes">et al.</italic>, 1994<xref ref-type="bibr" rid="bb20"> ▸</xref>; Ohlendorf, 1994<xref ref-type="bibr" rid="bb62"> ▸</xref>). However, more recently it has been shown that structures of globular proteins can indeed be solved to a very high precision (Liebschner <italic toggle="yes">et al.</italic>, 2013<xref ref-type="bibr" rid="bb43"> ▸</xref>).</p><p>As one relevant example, consider three structures of the well known model protein ubiquitin, <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1ubq" xmlns:xlink="http://www.w3.org/1999/xlink">1ubq</ext-link> (Vijay-Kumar <italic toggle="yes">et al.</italic>, 1987<xref ref-type="bibr" rid="bb86"> ▸</xref>), <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=1ubi" xmlns:xlink="http://www.w3.org/1999/xlink">1ubi</ext-link> (Ramage <italic toggle="yes">et al.</italic>, 1994<xref ref-type="bibr" rid="bb67"> ▸</xref>) and <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=4xof" xmlns:xlink="http://www.w3.org/1999/xlink">4xof</ext-link> (Ma <italic toggle="yes">et al.</italic>, 2015<xref ref-type="bibr" rid="bb49"> ▸</xref>). The structures were solved independently in the space group <italic toggle="yes">P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> with crystallographic resolutions of 1.80, 1.80 and 1.15 Å, respectively. Considering the well-structured body of ubiquitin, residues 2–72, we find that pairwise all-atom RMSD values for these three structures fall in the range 0.11–0.20 Å. This is similar to what we found for our LCB2 structures. This is also in line with various empirical estimates of structure accuracy, such as the Luzzati plot (Luzzati, 1952<xref ref-type="bibr" rid="bb48"> ▸</xref>), the σ<sub><italic toggle="yes">A</italic></sub> plot (Read, 1986<xref ref-type="bibr" rid="bb70"> ▸</xref>), Cruickshank’s DPI (Cruickshank, 1999<xref ref-type="bibr" rid="bb19"> ▸</xref>) and others, which assume that crystallographic structures are affected by random errors obeying a normal distribution. As a cautionary note, the presence of divalent ions in the same orthorhombic ubiquitin crystals as discussed above immediately increases the RMSD values to a level of <italic toggle="yes">ca</italic> 0.5 Å (Bang <italic toggle="yes">et al.</italic>, 2005<xref ref-type="bibr" rid="bb5"> ▸</xref>; Ma <italic toggle="yes">et al.</italic>, 2015<xref ref-type="bibr" rid="bb49"> ▸</xref>). Likewise, proteins crystallized in different space groups or with different ligands, as well as proteins carrying point mutations or post-translationally modified residues, often differ by 0.5–1.0 Å or more (Burra <italic toggle="yes">et al.</italic>, 2009<xref ref-type="bibr" rid="bb12"> ▸</xref>). In addition, when crystallographic structures are modeled using conformational ensembles (as opposed to the traditional single-model representation), the coordinate variance within such ensembles tends to be larger than the 0.10–0.25 Å observed in this study (Zoete <italic toggle="yes">et al.</italic>, 2002<xref ref-type="bibr" rid="bb93"> ▸</xref>; DePristo <italic toggle="yes">et al.</italic>, 2004<xref ref-type="bibr" rid="bb23"> ▸</xref>).</p><p>In addition to RMSD, we also used two other metrics to quantify the structural differences between the MR models and their descendant structures: global distance test – high accuracy (GDT-HA) and the local distance difference test (LDDT). The former quantity provides a better measure of overall structural similarity (de-emphasizing local deviations in the loop or termini regions), while the latter focuses on local similarities (de-emphasizing more global variations that may, for instance, arise from relative positioning of domains in a multidomain protein) (Olechnovič <italic toggle="yes">et al.</italic>, 2019<xref ref-type="bibr" rid="bb63"> ▸</xref>). The results are shown in Fig. S2, corroborating the discussion of the RMSD map above.</p><p>Finally, it is convenient to visualize the convergence of the structure determination procedure using principal component analysis (PCA) (Jolliffe, 2002<xref ref-type="bibr" rid="bb33"> ▸</xref>). In applying this method, a special coordinate frame is employed where each of the 12 analyzed models is represented by a set of coordinates {PC1, PC2, PC3, …, PC11} such that PC1 represents the most variation and PC2 represents the second most variation in the structural data. Hence, a PC1–PC2 map puts on display the most significant differences between the structures (see the supporting information for a complete description of the method).</p><p>Shown in Fig. 3<xref ref-type="fig" rid="fig3"> ▸</xref> is a PC1–PC2 map containing six computer-generated MR models of LCB2 (solid circles) and six final structures (open circles). The identities of the models and structures are color coded as indicated in the legend, and the related models and structures are connected by arrow lines. It is immediately obvious from the plot that the MR models are sufficiently diverse and far removed from the final structures, whereas the final structures are tightly clustered, <italic toggle="yes">i.e.</italic> nearly identical. The plot nicely illustrates the convergence of the structure determination procedure as implemented in this study.</p><p>Of note, the PCA method allows one to visualize structural changes associated with PC1 and, separately, with PC2 (see the supporting information for additional information). Making use of this option, we determined that PC1 represents a mixture of the two modes: conformational change in the loop 42–44 and the positional shift of the third α-helix. Independently, the shift of the third helix is also parameterized by PC2. We further found that the combination of PC1 and PC2 fully captures the backbone variations shown in Figs. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">a</italic>)–1(<italic toggle="yes">f</italic>).</p></sec><sec id="sec3.2"><label>3.2.</label><title>Conformational dynamics</title><p>While the backbone of LCB2 is almost perfectly reproduced from one solution to another, see Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">h</italic>), the situation with the side chains is more nuanced. While most of side chains are likewise reproduced, some of them are solved with different conformations, see Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>(<italic toggle="yes">i</italic>). As one such example consider the side chain Glu53 illustrated in Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref>. In the structures derived from the <italic toggle="yes">AlphaFold3</italic>, <italic toggle="yes">AlphaFold2</italic> and <italic toggle="yes">RoseTTAFold</italic> models, this side chain adopts the conformational state tt<underline> 0°</underline> according to the classification by Lovell and co-workers (Lovell <italic toggle="yes">et al.</italic>, 2000<xref ref-type="bibr" rid="bb47"> ▸</xref>). This particular glutamate conformation is rather common in the PDB (specifically, in α-helices its estimated frequency of occurrence is 25%); in the structures at hand it is additionally stabilized by ionic interaction with the nearby Arg57 side chain. In contrast, in the structures derived from the <italic toggle="yes">MultiFOLD</italic> and <italic toggle="yes">trRosetta</italic> models, the Glu53 side chain is found in a different conformational state, mm-40° (frequency of occurrence in α-helices 19%), which is stabilized by apparent ionic interactions to Arg52 and Lys56. Finally, the structure descendent from the <italic toggle="yes">Rosetta</italic> model features Glu53 in yet another conformational state, mt<underline>-10</underline>° (frequency of occurrence in α-helices 36%).</p><p>Let us summarize some observations regarding the Glu53 side chain as shown in Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref>. The weak electron density and elevated <italic toggle="yes">B</italic> factors suggest that the Glu53 side chain undergoes conformational dynamics. For this side chain our structure calculations lead to three different rotameric states, all of them clearly visible in the 2<italic toggle="yes">mF</italic><sub>o</sub> − <italic toggle="yes">DF</italic><sub>c</sub> map plotted at the 1σ level. In all cases but one (the <italic toggle="yes">Rosetta</italic>-based structure) the electron density does not offer any evidence of alternative conformations. Our attempts to model the Glu53 side chain using alternative conformations were unconvincing.</p><p>Strictly speaking, the results shown in Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref> constitute an example of model bias, <italic toggle="yes">i.e.</italic> the situation where the final solution depends on a prior model. To further explore this point, we compiled a set of OMIT maps focused on the Glu53 residue. Specifically, we took the six refined LCB2 structures, deleted their Glu53 side chains, and used the resulting constructs to generate electron density maps. It turned out that these OMIT maps showed essentially no observable density for the Glu53 side chain, thus confirming the notion of model bias (see Fig. S5).</p><p>Traditionally, the effect of model bias in protein crystallography is viewed in a purely negative light, as a potential source of structural error. In this particular case, however, we argue that model bias can be seen from a different angle. We suggest that the Glu53 side chain is conformationally labile with several substantially populated conformational states. Assume for a moment that we have obtained a (highly refined) LCB2 model where the Glu53 side chain happens to reproduce one of these populated states. Using such a (faithful) model allows us to ‘tease out’ the electron density corresponding to this particular populated rotamer. Therefore, we argue that the results in Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref> represent the actual Glu53 rotamers that are significantly populated in the LCB2 crystal.</p><p>This kind of logic leads us to further suggest that LCB2 models with incorrect Glu53 side-chain conformations (<italic toggle="yes">i.e.</italic>the ones that correspond to unpopulated or minimally populated rotamers) should fail to produce a viable solution. To test this assumption, we started with the fully refined LCB2 structure (<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link>, descendent from the <italic toggle="yes">AlphaFold3</italic> model) and placed the Glu53 side chain into one of the following conformational states: pm0°, tm-20°, pt<underline>-20°</underline>, tp10° or mp0° (<italic toggle="yes">i.e.</italic> all possible rotameric states except those three that have been already sampled, <italic toggle="yes">cf</italic>. Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref>). The resulting models were further used to generate the electron density maps, as shown in Fig. 5<xref ref-type="fig" rid="fig5"> ▸</xref>.</p><p>The inspection of Fig. 5<xref ref-type="fig" rid="fig5"> ▸</xref> shows that one of the models, tm-20°, is more-or-less consistent with the electron density, whereas the remaining four, pm0°, pt<underline>-20°</underline>, tp10° and mp0°, clearly fail the test as shown by negative density (red mesh). This outcome is in agreement with our interpretation, <italic toggle="yes">i.e.</italic> those models that match the actual side-chain conformations are supported by the electron density analyses, while other models are inconsistent with their associated electron density maps and hence can be discarded. A summary of the crystallographic results is presented in Fig. 6<xref ref-type="fig" rid="fig6"> ▸</xref>(<italic toggle="yes">a</italic>). In this plot, the six electron-density-supported conformations from Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref> are shown with red asterisks and, in addition, the electron-density-supported conformation tm-20° from Fig. 5<xref ref-type="fig" rid="fig5"> ▸</xref> is shown with a red circle.</p><p>To obtain further insight into the conformational dynamics of Glu53, we turn to MD simulations. In short, we used the six LCB2 structures obtained in this study to prepare six distinct models of the crystal unit cell (UC). Each UC model contained multiple protein molecules as well as intracrystalline solvent, which is explicitly represented by the optimal point charge (OPC) water (Izadi <italic toggle="yes">et al.</italic>, 2014<xref ref-type="bibr" rid="bb32"> ▸</xref>). For each UC model we then recorded a 1 µs MD trajectory using the <italic toggle="yes">Amber 2020</italic> program (Case <italic toggle="yes">et al.</italic>, 2020<xref ref-type="bibr" rid="bb15"> ▸</xref>) with the ff19SB force field (Tian <italic toggle="yes">et al.</italic>, 2020<xref ref-type="bibr" rid="bb84"> ▸</xref>). To emulate the crystal lattice, periodic boundary conditions were applied to the unit-cell faces. The trajectories were recorded at 300 K in the isothermal–isobaric (NPT) ensemble using the Bussi–Parrinello velocity rescaling thermostat (Bussi <italic toggle="yes">et al.</italic>, 2007<xref ref-type="bibr" rid="bb13"> ▸</xref>) (see the supporting information for further details).</p><p>In analyzing the MD data, we focused specifically on the conformation of the Glu53 side chain. Initially, each UC model featured its own Glu53 conformation, as illustrated in Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref>. However, as MD simulation progressed we observed Glu53 jumping from one rotameric state to another, eventually sampling a multitude of different conformations. The resulting rotamer distributions can be conveniently represented in the form of (χ<sub>1</sub>, χ<sub>2</sub>) heat maps; the third angle in the glutamate side chain, χ<sub>3</sub>, is only minimally restrained (Lovell <italic toggle="yes">et al.</italic>, 2000<xref ref-type="bibr" rid="bb47"> ▸</xref>). Since the Glu53 side chain is highly dynamic, all six MD trajectories lead to near-identical distributions, thus indicating good convergence of the simulations, see Fig. S6. One representative map is shown in Fig. 6<xref ref-type="fig" rid="fig6"> ▸</xref>(<italic toggle="yes">b</italic>) (corresponding to the simulation that was started from the crystal coordinates of <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link>).</p><p>Let us now review the results in Fig. 6<xref ref-type="fig" rid="fig6"> ▸</xref>. According to the MD data, there are three rotameric states that are sparsely populated (at the level of less than 1%): pm0°, pt<underline>-20°</underline> and mp0°. Indeed, none of these three rotameric states has been detected crystallographically, <italic toggle="yes">i.e.</italic> via electron density analyses. On the other hand, there are five rotameric states that are appreciably populated: tm-20°, mm-40°, tt<underline> 0°</underline>, mt<underline>-10°</underline> and tp10°. Four of these five states have been detected crystallographically. The sole exception is tp10°, which deserves a separate comment. According to the MD data, the population of this state reaches 65%. Note, however, that structural statistics reported by Lovell <italic toggle="yes">et al.</italic> suggest otherwise: on average, this conformational state is populated at the level of 6%, while specifically in α-helices it is populated at the level of 10% (Lovell <italic toggle="yes">et al.</italic>, 2000<xref ref-type="bibr" rid="bb47"> ▸</xref>). Therefore, one may assume that MD simulations exaggerate the population of the tp10° state, which would explain why this conformation is not registered in our crystallographic study.</p><p>Moving beyond the Glu53 side chain, we assume that more generally multiple LCB2 structures obtained in this study can be viewed as an ensemble that is representative of the protein’s conformational dynamics. If so, then this six-member ensemble should give rise to lower values of <italic toggle="yes">R</italic><sub>work</sub>/<italic toggle="yes">R</italic><sub>free</sub>. Indeed, using the ensemble model comprising six LCB2 structures we arrive at the <italic toggle="yes">R</italic> factors of 0.187/0.220. This is significantly better than any of the structures taken alone; in fact, the best result from the individual structure is a good deal worse at 0.208/0.240 (see Table 2<xref ref-type="table" rid="table2"> ▸</xref>). Thus, we conclude that the collection of LCB2 structures obtained from the multi-start structure determination procedure as implemented in this work offers a useful (and in certain ways unique) representation of protein dynamics.</p></sec></sec><sec id="sec4" sec-type="conclusions"><label>4.</label><title>Concluding remarks</title><p>Fig. 7<xref ref-type="fig" rid="fig7"> ▸</xref> illustrates, in a schematic form, the process of solving a protein’s crystallographic structure. The objective function in the plot is the measure of agreement between the experimental and calculated structure factors. In practice, this is usually the maximum likelihood function (Murshudov <italic toggle="yes">et al.</italic>, 1997<xref ref-type="bibr" rid="bb59"> ▸</xref>); alternatively, for the purpose of this discussion, it can be interpreted as the residual sum of squares or, otherwise, as the <italic toggle="yes">R</italic> factor. The generalized coordinate in the plot represents the complete set of atomic coordinates that defines the protein structure.</p><p>Solving the structure or, in a more narrow sense, refining the structure entails minimization of the objective function over the space of atomic coordinates. The process begins with an imprecise initial model (solid circle) and ends with a highly accurate structure (open circle). Up to a certain point, the minimization lowers the value of the objective function, until finally it arrives at the bottom of the well, where the algorithm settles in one of the multiple local minima (within the gray band in Fig. 7<xref ref-type="fig" rid="fig7"> ▸</xref>).</p><p>The multiple solutions are nearly identical, yet they differ from each other in certain subtle ways (<italic toggle="yes">e.g.</italic> with regard to conformations of certain side chains). Following DePristo, we argue that these solutions are equally valid (DePristo <italic toggle="yes">et al.</italic>, 2004<xref ref-type="bibr" rid="bb23"> ▸</xref>). Small variations in <italic toggle="yes">R</italic><sub>free</sub> or other validation metrics are inconsequential and do not allow one to select the ‘best’ structure (<italic toggle="yes">cf</italic>. Table 2<xref ref-type="table" rid="table2"> ▸</xref>).</p><p>The multiplicity of the closely related solutions (numerous local minima within the gray band in the plot) stems from two factors: (1) conformational variability of the protein structure, <italic toggle="yes">i.e.</italic> local dynamics, and (2) uncertainty that is present in the diffraction data, <italic toggle="yes">i.e.</italic> limited resolution (Terwilliger <italic toggle="yes">et al.</italic>, 2007<xref ref-type="bibr" rid="bb83"> ▸</xref>). The latter is itself mainly a consequence of dynamics, but also includes contributions from crystal defects, occasional radiation damage, finite accuracy of the X-ray detection system, approximate nature of the bulk solvent model <italic toggle="yes">etc</italic>. (Levin <italic toggle="yes">et al.</italic>, 2007<xref ref-type="bibr" rid="bb40"> ▸</xref>; Holton <italic toggle="yes">et al.</italic>, 2014<xref ref-type="bibr" rid="bb29"> ▸</xref>; Ma <italic toggle="yes">et al.</italic>, 2015<xref ref-type="bibr" rid="bb49"> ▸</xref>).</p><p>It has long been recognized that using ensemble models instead of single-conformer models leads to somewhat better structural statistics. Broadly speaking, ensemble models can be generated by means of multi-copy optimization (Pellegrini <italic toggle="yes">et al.</italic>, 1997<xref ref-type="bibr" rid="bb64"> ▸</xref>) or otherwise multi-start optimization (Rice <italic toggle="yes">et al.</italic>, 1998<xref ref-type="bibr" rid="bb73"> ▸</xref>). The former approach involves simultaneous refinement of multiple protein copies, while the latter involves multiple (partially independent) refinement runs. It is believed that at higher crystallographic resolution ensemble models capture some of the actual conformational variability that is present in protein crystals and thus improve <italic toggle="yes">R</italic><sub>free</sub> and other measures of structural quality. At lower resolution, ensemble models still produce slightly better <italic toggle="yes">R</italic><sub>free</sub> values; in this case, the improvement is likely due to cancelation of small random errors associated with the individual solutions (similar to a standard procedure whereby the readouts from several repeat measurements are averaged to obtain a more accurate result).</p><p>The treatment described in this paper can be considered an example of multi-start refinement, where six final structures derived from different MR models are grouped together to form a small multiconformer ensemble. Unlike most implementations of ensemble refinement that were fully automated, we solved the structures using a traditional (labor-intensive) approach involving manual manipulations in <italic toggle="yes">Coot</italic>. In doing so, we observed an interesting effect whereby several dynamic side chains produced a different electron density footprint depending on the prior model. Apparently, when we use a (highly refined) model where the side-chain conformation corresponds to a rotameric state that is significantly populated in the actual crystal, we thereby elicit the electron density for this particular side-chain conformation. Conversely, when we use a model with an irrelevant (low-population) side-chain conformation, it fails to produce the matching electron density.</p><p>Strictly speaking, this behavior constitutes a case of model bias, <italic toggle="yes">i.e.</italic> certain details of the determined structure prove to be model dependent. We argue, however, that in the context of our study model bias plays a benign role, allowing us to characterize the rotameric distribution for the side chain at hand. Note that this would not be possible if we were to use standard tools for modeling of protein dynamics, such as alternative conformations.</p><p>One may wonder if the same result can be achieved by using a number of distinct structures derived from a single MR model (relying on the element of randomness which is present in both <italic toggle="yes">Coot</italic> manipulations and <italic toggle="yes">Phenix</italic> random-seeded refinement). To test this conjecture, we repeated the process of structure determination beginning from the <italic toggle="yes">AlphaFold2</italic>-predicted MR model. Indeed, we found several side chains adopting different conformations in the two <italic toggle="yes">AlphaFold2</italic>-derived solutions. As before, when considering individual structures, the electron density did not show any evidence of conformational dynamics at these sites. It is only through the comparison of the two structures that the conformational disorder became directly visible.</p><p>To further test the validity of rotameric distributions obtained for Glu53 and other dynamic side chains, we plan to use computer experiments (Levin <italic toggle="yes">et al.</italic>, 2007<xref ref-type="bibr" rid="bb40"> ▸</xref>; Terwilliger <italic toggle="yes">et al.</italic>, 2007<xref ref-type="bibr" rid="bb83"> ▸</xref>; van den Bedem <italic toggle="yes">et al.</italic>, 2009<xref ref-type="bibr" rid="bb85"> ▸</xref>; Liu <italic toggle="yes">et al.</italic>, 2023<xref ref-type="bibr" rid="bb45"> ▸</xref>). Specifically, we intend to simulate the diffraction data based on an MD trajectory of the LCB2 crystal and then use the simulated data to solve the protein structure using the same multi-start approach as described above. Comparison between the so-obtained multiconformer ensemble and the underlying MD model should directly confirm the interpretation presented in this work.</p><p>In summary, we have used six different computer-generated MR models to obtain a multiconformer ensemble for the small antiviral protein LCB2. While <italic toggle="yes">R</italic><sub>work</sub>/<italic toggle="yes">R</italic><sub>free</sub> of the individual structures is at best 0.208/0.240, the six-member ensemble yields significantly improved values, 0.187/0.220. The procedure described in this paper potentially offers a new way to probe side-chain dynamics beyond the conventional electron density inspection. The proposed modeling scheme should add to the arsenal of methods that have been developed to glean information on protein dynamics from X-ray crystallography data.</p></sec><sec id="sec5"><label>5.</label><title>Related literature</title><p>The following references are cited in the supporting information: Arbeitman <italic toggle="yes">et al.</italic> (2020<xref ref-type="bibr" rid="bb900"> ▸</xref>); Atakisi <italic toggle="yes">et al.</italic> (2018<xref ref-type="bibr" rid="bb901"> ▸</xref>); Berendsen <italic toggle="yes">et al.</italic> (1984<xref ref-type="bibr" rid="bb902"> ▸</xref>); Dunlop <italic toggle="yes">et al.</italic> (2005<xref ref-type="bibr" rid="bb903"> ▸</xref>); Essmann <italic toggle="yes">et al.</italic> (1995<xref ref-type="bibr" rid="bb904"> ▸</xref>); Halle (2004<xref ref-type="bibr" rid="bb905"> ▸</xref>); Hopkins <italic toggle="yes">et al.</italic> (2015<xref ref-type="bibr" rid="bb906"> ▸</xref>); Jurrus <italic toggle="yes">et al.</italic> (2018<xref ref-type="bibr" rid="bb907"> ▸</xref>); Kurauskas <italic toggle="yes">et al.</italic> (2017<xref ref-type="bibr" rid="bb908"> ▸</xref>); Lebedenko <italic toggle="yes">et al.</italic> (2024<xref ref-type="bibr" rid="bb909"> ▸</xref>); Poon (2010<xref ref-type="bibr" rid="bb910"> ▸</xref>); Vonrhein <italic toggle="yes">et al.</italic> (2011<xref ref-type="bibr" rid="bb911"> ▸</xref>); Webb &amp; Sali (2016<xref ref-type="bibr" rid="bb912"> ▸</xref>).</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" orientation="portrait" position="float"><p>Supporting information. DOI: <ext-link ext-link-type="doi" xlink:href="10.1107/S2052252525005123/lz5075sup1.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">10.1107/S2052252525005123/lz5075sup1.pdf</ext-link></p><media id="d67e168" orientation="portrait" position="anchor" xlink:href="m-12-00488-sup1.pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/></supplementary-material><supplementary-material content-type="local-data" orientation="portrait" position="float"><p>PDB reference: <ext-link ext-link-type="doi" xlink:href="10.2210/pdb8c3e/pdb" xmlns:xlink="http://www.w3.org/1999/xlink">engineered mini-protein LCB2 (blocking ligand of SARS-CoV-2 spike protein), 8c3e</ext-link></p></supplementary-material><supplementary-material content-type="local-data" orientation="portrait" position="float"><p>All six starting models, final structures and final electron density maps: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.15337018" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.5281/zenodo.15337018</ext-link></p></supplementary-material></sec></body><back><ack><p>Experimental measurements were conducted using the facilities of the Center for X-ray Diffraction Studies, Center for Molecular and Cell Technologies, Thermogravimetric and Calorimetric Research Center and Magnetic Resonance Research Center in the Research Park of SPbU. We are thankful to Andrei Fokine, Alexander Golubev, Boris Kharkov, Pavel Korban, Alexandra Levkina, Dmitrii Luzik and especially Olga Lebedenko for their help and advice with different aspects of this work. We are also grateful to Yi Xue and Valentin Borshchevskiy for productive collaborations in the area of protein crystallography</p></ack><sec sec-type="data-availability"><title>Data availability</title><p>The LCB2 structure obtained from the <italic toggle="yes">AlphaFold3</italic>-generated model has been deposited in Protein Data Bank (PDB ID <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link>). All six starting models, final structures and final electron density maps are available from the Zenodo repository, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.15337018" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi.org/10.5281/zenodo.15337018</ext-link>.</p></sec><ref-list><title>References</title><ref id="bb1"><mixed-citation publication-type="other">Abergel, C. (2013). <italic toggle="yes">Acta Cryst.</italic> D<bold>69</bold>, 2167–2173.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444913015291</pub-id><pub-id pub-id-type="pmcid">PMC3817689</pub-id><pub-id pub-id-type="pmid">24189227</pub-id></mixed-citation></ref><ref id="bb2"><mixed-citation publication-type="other">Abramson, J., Adler, J., Dunger, J., Evans, R., Green, T., Pritzel, A., Ronneberger, O., Willmore, L., Ballard, A. J., Bambrick, J., Bodenstein, S. W., Evans, D. A., Hung, C.-C., O’Neill, M., Reiman, D., Tunyasuvunakool, K., Wu, Z., Žemgulytė, A., Arvaniti, E., Beattie, C., Bertolli, O., Bridgland, A., Cherepanov, A., Congreve, M., Cowen-Rivers, A. I., Cowie, A., Figurnov, M., Fuchs, F. B., Gladman, H., Jain, R., Khan, Y. A., Low, C. M. R., Perlin, K., Potapenko, A., Savy, P., Singh, S., Stecula, A., Thillaisundaram, A., Tong, C., Yakneen, S., Zhong, E. D., Zielinski, M., Žídek, A., Bapst, V., Kohli, P., Jaderberg, M., Hassabis, D. &amp; Jumper, J. M. (2024). <italic toggle="yes">Nature</italic><bold>630</bold>, 493–500.</mixed-citation></ref><ref id="bb3"><mixed-citation publication-type="other">Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H. &amp; Adams, P. D. (2012). <italic toggle="yes">Acta Cryst.</italic> D<bold>68</bold>, 352–367.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444912001308</pub-id><pub-id pub-id-type="pmcid">PMC3322595</pub-id><pub-id pub-id-type="pmid">22505256</pub-id></mixed-citation></ref><ref id="bb900"><mixed-citation publication-type="other">Arbeitman, C. R., Auge, G., Blaustein, M., Bredeston, L., Corapi, E. S., Craig, P. O., Cossio, L. A., Dain, L., D’Alessio, C., Elias, F., Fernández, N. B., Gándola, Y. B., Gasulla, J., Gorojovsky, N., Gudesblat, G. E., Herrera, M. G., Ibañez, L. I., Idrovo, T., Rando, M. I., Kamenetzky, L., Nadra, A. D., Noseda, D. G., Paván, C. H., Pavan, M. F., Pignataro, M. F., Roman, E., Ruberto, L. A. M., Rubinstein, N., Santos, J., Velazquez, F. &amp; Zelada, A. M. (2020). <italic toggle="yes">Sci. Rep.</italic><bold>10</bold>, 21779. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/s41598-020-78711-6</pub-id><pub-id pub-id-type="pmcid">PMC7732851</pub-id><pub-id pub-id-type="pmid">33311634</pub-id></mixed-citation></ref><ref id="bb901"><mixed-citation publication-type="other">Atakisi, H., Moreau, D. W. &amp; Thorne, R. E. (2018). <italic toggle="yes">Acta Cryst.</italic> D<bold>74</bold>, 264–278. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798318000207</pub-id><pub-id pub-id-type="pmcid">PMC5892876</pub-id><pub-id pub-id-type="pmid">29652254</pub-id></mixed-citation></ref><ref id="bb4"><mixed-citation publication-type="other">Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R. D., Millán, C., Park, H., Adams, C., Glassman, C. R., DeGiovanni, A., Pereira, J. H., Rodrigues, A. V., van Dijk, A. A., Ebrecht, A. C., Opperman, D. J., Sagmeister, T., Buhlheller, C., Pavkov-Keller, T., Rathinaswamy, M. K., Dalwadi, U., Yip, C. K., Burke, J. E., Garcia, K. C., Grishin, N. V., Adams, P. D., Read, R. J. &amp; Baker, D. (2021). <italic toggle="yes">Science</italic><bold>373</bold>, 871–876.</mixed-citation></ref><ref id="bb5"><mixed-citation publication-type="other">Bang, D., Makhatadze, G. I., Tereshko, V., Kossiakoff, A. A. &amp; Kent, S. B. (2005). <italic toggle="yes">Angew. Chem. Int. Ed.</italic><bold>44</bold>, 3852–3856.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/anie.200463040</pub-id><pub-id pub-id-type="pmid">15834850</pub-id></mixed-citation></ref><ref id="bb6"><mixed-citation publication-type="other">Barbarin-Bocahu, I. &amp; Graille, M. (2022). <italic toggle="yes">Acta Cryst.</italic> D<bold>78</bold>, 517–531.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798322002157</pub-id><pub-id pub-id-type="pmid">35362474</pub-id></mixed-citation></ref><ref id="bb902"><mixed-citation publication-type="other">Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. &amp; Haak, J. R. (1984). <italic toggle="yes">J. Chem. Phys.</italic><bold>81</bold>, 3684–3690. </mixed-citation></ref><ref id="bb7"><mixed-citation publication-type="other">Bibby, J., Keegan, R. M., Mayans, O., Winn, M. D. &amp; Rigden, D. J. (2012). <italic toggle="yes">Acta Cryst.</italic> D<bold>68</bold>, 1622–1631.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444912039194</pub-id><pub-id pub-id-type="pmid">23151627</pub-id></mixed-citation></ref><ref id="bb8"><mixed-citation publication-type="other">Boyken, S. E., Benhaim, M. A., Busch, F., Jia, M., Bick, M. J., Choi, H., Klima, J. C., Chen, Z., Walkey, C., Mileant, A., Sahasrabuddhe, A., Wei, K. Y., Hodge, E. A., Byron, S., Quijano-Rubio, A., Sankaran, B., King, N. P., Lippincott-Schwartz, J., Wysocki, V. H., Lee, K. K. &amp; Baker, D. (2019). <italic toggle="yes">Science</italic><bold>364</bold>, 658–664.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1126/science.aav7897</pub-id><pub-id pub-id-type="pmcid">PMC7072037</pub-id><pub-id pub-id-type="pmid">31097662</pub-id></mixed-citation></ref><ref id="bb9"><mixed-citation publication-type="other">Bunkóczi, G., Echols, N., McCoy, A. J., Oeffner, R. D., Adams, P. D. &amp; Read, R. J. (2013). <italic toggle="yes">Acta Cryst.</italic> D<bold>69</bold>, 2276–2286.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444913022750</pub-id><pub-id pub-id-type="pmcid">PMC3817702</pub-id><pub-id pub-id-type="pmid">24189240</pub-id></mixed-citation></ref><ref id="bb10"><mixed-citation publication-type="other">Bunkóczi, G. &amp; Read, R. (2011<italic toggle="yes">a</italic>). <italic toggle="yes">Comput. Crystallogr. Newsl.</italic><bold>2</bold>, 8–9.</mixed-citation></ref><ref id="bb11"><mixed-citation publication-type="other">Bunkóczi, G. &amp; Read, R. J. (2011<italic toggle="yes">b</italic>). <italic toggle="yes">Acta Cryst.</italic> D<bold>67</bold>, 303–312.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444910051218</pub-id><pub-id pub-id-type="pmcid">PMC3069745</pub-id><pub-id pub-id-type="pmid">21460448</pub-id></mixed-citation></ref><ref id="bb12"><mixed-citation publication-type="other">Burra, P. V., Zhang, Y., Godzik, A. &amp; Stec, B. (2009). <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>106</bold>, 10505–10510.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1073/pnas.0812152106</pub-id><pub-id pub-id-type="pmcid">PMC2705611</pub-id><pub-id pub-id-type="pmid">19553204</pub-id></mixed-citation></ref><ref id="bb13"><mixed-citation publication-type="other">Bussi, G., Donadio, D. &amp; Parrinello, M. (2007). <italic toggle="yes">J. Chem. Phys.</italic><bold>126</bold>, 014101.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1063/1.2408420</pub-id><pub-id pub-id-type="pmid">17212484</pub-id></mixed-citation></ref><ref id="bb14"><mixed-citation publication-type="other">Cao, L., Goreshnik, I., Coventry, B., Case, J. B., Miller, L., Kozodoy, L., Chen, R. E., Carter, L., Walls, A. C., Park, Y.-J., Strauch, E.-M., Stewart, L., Diamond, M. S., Veesler, D. &amp; Baker, D. (2020). <italic toggle="yes">Science</italic><bold>370</bold>, 426–431.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1126/science.abd9909</pub-id><pub-id pub-id-type="pmcid">PMC7857403</pub-id><pub-id pub-id-type="pmid">32907861</pub-id></mixed-citation></ref><ref id="bb15"><mixed-citation publication-type="other">Case, D. A., Belfon, K., Ben-Shalom, I. Y., Brozell, S. R., Cerutti, D. S., Cheatham, T. E., Cruzeiro, V. W. D., Darden, T. A., Duke, R. E., Giambasu, G., Gilson, M. K., Gohlke, H., Goetz, A. W., Harris, R., Izadi, S., Izmailov, S. A., Kasavajhala, K., Kovalenko, A., Krasny, R., Kurtzman, T., Lee, T. S., LeGrand, S., Li, P., Lin, C., Liu, J., Luchko, T., Luo, R., Man, V., Merz, K. M., Miao, Y., Mikhailovskii, O., Monard, G., Nguyen, H., Onufriev, A., Pan, F., Pantano, S., Qi, R., Roe, D. R., Roitberg, A., Sagui, C., Schott-Verdugo, S., Shen, J., Simmerling, C. L., Skrynnikov, N. R., Smith, J., Swails, J., Walker, R. C., Wang, J., Wilson, L., Wolf, R. M., Wu, X., Xiong, Y., Xue, Y., York, D. M. &amp; Kollman, P. A. (2020). <italic toggle="yes">Amber 2020.</italic> San Francisco: University of California.</mixed-citation></ref><ref id="bb16"><mixed-citation publication-type="other">Case, J. B., Chen, R. E., Cao, L., Ying, B., Winkler, E. S., Johnson, M., Goreshnik, I., Pham, M. N., Shrihari, S., Kafai, N. M., Bailey, A. L., Xie, X., Shi, P.-Y., Ravichandran, R., Carter, L., Stewart, L., Baker, D. &amp; Diamond, M. S. (2021). <italic toggle="yes">Cell Host Microbe</italic><bold>29</bold>, 1151–1161.e5.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.chom.2021.06.008</pub-id><pub-id pub-id-type="pmcid">PMC8221914</pub-id><pub-id pub-id-type="pmid">34192518</pub-id></mixed-citation></ref><ref id="bb17"><mixed-citation publication-type="other">Chen, Z., Boyken, S. E., Jia, M., Busch, F., Flores-Solis, D., Bick, M. J., Lu, P., VanAernum, Z. L., Sahasrabuddhe, A., Langan, R. A., Bermeo, S., Brunette, T. J., Mulligan, V. K., Carter, L. P., DiMaio, F., Sgourakis, N. G., Wysocki, V. H. &amp; Baker, D. (2019). <italic toggle="yes">Nature</italic><bold>565</bold>, 106–111.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/s41586-018-0802-y</pub-id><pub-id pub-id-type="pmcid">PMC6537907</pub-id><pub-id pub-id-type="pmid">30568301</pub-id></mixed-citation></ref><ref id="bb18"><mixed-citation publication-type="other">Claude, J. B., Suhre, K., Notredame, C., Claverie, J. M. &amp; Abergel, C. (2004). <italic toggle="yes">Nucleic Acids Res.</italic><bold>32</bold>, W606–W609.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1093/nar/gkh400</pub-id><pub-id pub-id-type="pmcid">PMC441538</pub-id><pub-id pub-id-type="pmid">15215460</pub-id></mixed-citation></ref><ref id="bb19"><mixed-citation publication-type="other">Cruickshank, D. W. J. (1999). <italic toggle="yes">Acta Cryst.</italic> D<bold>55</bold>, 583–601.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/s0907444998012645</pub-id><pub-id pub-id-type="pmid">10089455</pub-id></mixed-citation></ref><ref id="bb20"><mixed-citation publication-type="other">Daopin, S., Davies, D. R., Schlunegger, M. P. &amp; Grütter, M. G. (1994). <italic toggle="yes">Acta Cryst.</italic> D<bold>50</bold>, 85–92.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S090744499300808X</pub-id><pub-id pub-id-type="pmid">15299480</pub-id></mixed-citation></ref><ref id="bb21"><mixed-citation publication-type="other">Das, R. &amp; Baker, D. (2008). <italic toggle="yes">Annu. Rev. Biochem.</italic><bold>77</bold>, 363–382.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1146/annurev.biochem.77.062906.171838</pub-id><pub-id pub-id-type="pmid">18410248</pub-id></mixed-citation></ref><ref id="bb22"><mixed-citation publication-type="other">Das, R. &amp; Baker, D. (2009). <italic toggle="yes">Acta Cryst.</italic> D<bold>65</bold>, 169–175.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444908020039</pub-id><pub-id pub-id-type="pmcid">PMC2631639</pub-id><pub-id pub-id-type="pmid">19171972</pub-id></mixed-citation></ref><ref id="bb23"><mixed-citation publication-type="other">DePristo, M. A., de Bakker, P. I. W. &amp; Blundell, T. L. (2004). <italic toggle="yes">Structure</italic><bold>12</bold>, 831–838.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.str.2004.02.031</pub-id><pub-id pub-id-type="pmid">15130475</pub-id></mixed-citation></ref><ref id="bb24"><mixed-citation publication-type="other">Du, Z., Su, H., Wang, W., Ye, L., Wei, H., Peng, Z., Anishchenko, I., Baker, D. &amp; Yang, J. (2021). <italic toggle="yes">Nat. Protoc.</italic><bold>16</bold>, 5634–5651.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/s41596-021-00628-9</pub-id><pub-id pub-id-type="pmid">34759384</pub-id></mixed-citation></ref><ref id="bb903"><mixed-citation publication-type="other">Dunlop, K. V., Irvin, R. T. &amp; Hazes, B. (2005). <italic toggle="yes">Acta Cryst.</italic> D<bold>61</bold>, 80–87. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444904027179</pub-id><pub-id pub-id-type="pmid">15608379</pub-id></mixed-citation></ref><ref id="bb25"><mixed-citation publication-type="other">Emsley, P., Lohkamp, B., Scott, W. G. &amp; Cowtan, K. (2010). <italic toggle="yes">Acta Cryst.</italic> D<bold>66</bold>, 486–501.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmcid">PMC2852313</pub-id><pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation></ref><ref id="bb904"><mixed-citation publication-type="other">Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H. &amp; Pedersen, L. G. (1995). <italic toggle="yes">J. Chem. Phys.</italic><bold>103</bold>, 8577–8593. </mixed-citation></ref><ref id="bb26"><mixed-citation publication-type="other">Evans, P. &amp; McCoy, A. (2008). <italic toggle="yes">Acta Cryst.</italic> D<bold>64</bold>, 1–10.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444907051554</pub-id><pub-id pub-id-type="pmcid">PMC2394790</pub-id><pub-id pub-id-type="pmid">18094461</pub-id></mixed-citation></ref><ref id="bb27"><mixed-citation publication-type="other">Guex, N. &amp; Peitsch, M. C. (1997). <italic toggle="yes">Electrophoresis</italic><bold>18</bold>, 2714–2723.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/elps.1150181505</pub-id><pub-id pub-id-type="pmid">9504803</pub-id></mixed-citation></ref><ref id="bb905"><mixed-citation publication-type="other">Halle, B. (2004). <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>101</bold>, 4793–4798. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1073/pnas.0308315101</pub-id><pub-id pub-id-type="pmcid">PMC387327</pub-id><pub-id pub-id-type="pmid">15051877</pub-id></mixed-citation></ref><ref id="bb28"><mixed-citation publication-type="other">Hodel, A., Kim, S.-H. &amp; Brünger, A. T. (1992). <italic toggle="yes">Acta Cryst.</italic> A<bold>48</bold>, 851–858.</mixed-citation></ref><ref id="bb29"><mixed-citation publication-type="other">Holton, J. M., Classen, S., Frankel, K. A. &amp; Tainer, J. A. (2014). <italic toggle="yes">FEBS J.</italic><bold>281</bold>, 4046–4060.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1111/febs.12922</pub-id><pub-id pub-id-type="pmcid">PMC4282448</pub-id><pub-id pub-id-type="pmid">25040949</pub-id></mixed-citation></ref><ref id="bb906"><mixed-citation publication-type="other">Hopkins, C. W., Le Grand, S., Walker, R. C. &amp; Roitberg, A. E. (2015). <italic toggle="yes">J. Chem. Theory Comput.</italic><bold>11</bold>, 1864–1874. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1021/ct5010406</pub-id><pub-id pub-id-type="pmid">26574392</pub-id></mixed-citation></ref><ref id="bb30"><mixed-citation publication-type="other">Huang, B., Kong, L., Wang, C., Ju, F., Zhang, Q., Zhu, J., Gong, T., Zhang, H., Yu, C., Zheng, W.-M. &amp; Bu, D. (2023). <italic toggle="yes">Genom. Proteom. Bioinform.</italic><bold>21</bold>, 913–925.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.gpb.2022.11.014</pub-id><pub-id pub-id-type="pmcid">PMC10928435</pub-id><pub-id pub-id-type="pmid">37001856</pub-id></mixed-citation></ref><ref id="bb31"><mixed-citation publication-type="other">Hunt, A. C., Case, J. B., Park, Y.-J., Cao, L., Wu, K., Walls, A. C., Liu, Z., Bowen, J. E., Yeh, H.-W., Saini, S., Helms, L., Zhao, Y. T., Hsiang, T.-Y., Starr, T. N., Goreshnik, I., Kozodoy, L., Carter, L., Ravichandran, R., Green, L. B., Matochko, W. L., Thomson, C. A., Vogeli, B., Kruger, A., VanBlargan, L. A., Chen, R. E., Ying, B., Bailey, A. L., Kafai, N. M., Boyken, S. E., Ljubetic, A., Edman, N., Ueda, G., Chow, C. M., Johnson, M., Addetia, A., Navarro, M.-J., Panpradist, N., Gale, M. Jr, Freedman, B. S., Bloom, J. D., Ruohola-Baker, H., Whelan, S. P. J., Stewart, L., Diamond, M. S., Veesler, D., Jewett, M. C. &amp; Baker, D. (2022). <italic toggle="yes">Sci. Transl. Med.</italic><bold>14</bold>, eabn1252.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1126/scitranslmed.abn1252</pub-id><pub-id pub-id-type="pmcid">PMC9258422</pub-id><pub-id pub-id-type="pmid">35412328</pub-id></mixed-citation></ref><ref id="bb32"><mixed-citation publication-type="other">Izadi, S., Anandakrishnan, R. &amp; Onufriev, A. V. (2014). <italic toggle="yes">J. Phys. Chem. Lett.</italic><bold>5</bold>, 3863–3871.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1021/jz501780a</pub-id><pub-id pub-id-type="pmcid">PMC4226301</pub-id><pub-id pub-id-type="pmid">25400877</pub-id></mixed-citation></ref><ref id="bb33"><mixed-citation publication-type="other">Jolliffe, I. T. (2002). <italic toggle="yes">Principal component analysis</italic>. 2nd ed. New York: Springer.</mixed-citation></ref><ref id="bb34"><mixed-citation publication-type="other">Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., Back, T., Petersen, S., Reiman, D., Clancy, E., Zielinski, M., Steinegger, M., Pacholska, M., Berghammer, T., Bodenstein, S., Silver, D., Vinyals, O., Senior, A. W., Kavukcuoglu, K., Kohli, P. &amp; Hassabis, D. (2021). <italic toggle="yes">Nature</italic><bold>596</bold>, 583–589.</mixed-citation></ref><ref id="bb907"><mixed-citation publication-type="other">Jurrus, E., Engel, D., Star, K., Monson, K., Brandi, J., Felberg, L. E., Brookes, D. H., Wilson, L., Chen, J., Liles, K., Chun, M., Li, P., Gohara, D. W., Dolinsky, T., Konecny, R., Koes, D. R., Nielsen, J. E., Head–Gordon, T., Geng, W., Krasny, R., Wei, G. W., Holst, M. J., McCammon, J. A. &amp; Baker, N. A. (2018). <italic toggle="yes">Protein Sci.</italic><bold>27</bold>, 112–128. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/pro.3280</pub-id><pub-id pub-id-type="pmcid">PMC5734301</pub-id><pub-id pub-id-type="pmid">28836357</pub-id></mixed-citation></ref><ref id="bb35"><mixed-citation publication-type="other">Keegan, R. M., Bibby, J., Thomas, J., Xu, D., Zhang, Y., Mayans, O., Winn, M. D. &amp; Rigden, D. J. (2015). <italic toggle="yes">Acta Cryst.</italic> D<bold>71</bold>, 338–343.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S1399004714025784</pub-id><pub-id pub-id-type="pmcid">PMC4321487</pub-id><pub-id pub-id-type="pmid">25664744</pub-id></mixed-citation></ref><ref id="bb36"><mixed-citation publication-type="other">Keegan, R. M., Simpkin, A. J. &amp; Rigden, D. J. (2024). <italic toggle="yes">Acta Cryst.</italic> D<bold>80</bold>, 766–779.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798324009380</pub-id><pub-id pub-id-type="pmcid">PMC11544426</pub-id><pub-id pub-id-type="pmid">39360967</pub-id></mixed-citation></ref><ref id="bb37"><mixed-citation publication-type="other">Keegan, R. M. &amp; Winn, M. D. (2007). <italic toggle="yes">Acta Cryst.</italic> D<bold>63</bold>, 447–457.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444907002661</pub-id><pub-id pub-id-type="pmid">17372348</pub-id></mixed-citation></ref><ref id="bb38"><mixed-citation publication-type="other">Kleywegt, G. J. &amp; Jones, T. (1996). <italic toggle="yes">Jnt. <italic toggle="yes">CCP4</italic>/ESF-EACBM Newsl. Protein Crystallogr.</italic><bold>32</bold>, 32–36.</mixed-citation></ref><ref id="bb39"><mixed-citation publication-type="other">Kryshtafovych, A., Moult, J., Albrecht, R., Chang, G. A., Chao, K., Fraser, A., Greenfield, J., Hartmann, M. D., Herzberg, O., Josts, I., Leiman, P. G., Linden, S. B., Lupas, A. N., Nelson, D. C., Rees, S. D., Shang, X., Sokolova, M. L. &amp; Tidow, H. (2021). <italic toggle="yes">Proteins</italic><bold>89</bold>, 1633–1646.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.26223</pub-id><pub-id pub-id-type="pmcid">PMC8616789</pub-id><pub-id pub-id-type="pmid">34449113</pub-id></mixed-citation></ref><ref id="bb908"><mixed-citation publication-type="other">Kurauskas, V., Izmailov, S. A., Rogacheva, O. N., Hessel, A., Ayala, I., Woodhouse, J., Shilova, A., Xue, Y., Yuwen, T., Coquelle, N., Colletier, J. P., Skrynnikov, N. R. &amp; Schanda, P. (2017). <italic toggle="yes">Nat. Commun.</italic><bold>8</bold>, 145. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/s41467-017-00165-8</pub-id><pub-id pub-id-type="pmcid">PMC5529581</pub-id><pub-id pub-id-type="pmid">28747759</pub-id></mixed-citation></ref><ref id="bb909"><mixed-citation publication-type="other">Lebedenko, O. O., Salikov, V. A., Izmailov, S. A., Podkorytov, I. S. &amp; Skrynnikov, N. R. (2024). <italic toggle="yes">Biophys. J.</italic><bold>123</bold>, 80–100. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.bpj.2023.11.020</pub-id><pub-id pub-id-type="pmcid">PMC10808029</pub-id><pub-id pub-id-type="pmid">37990496</pub-id></mixed-citation></ref><ref id="bb40"><mixed-citation publication-type="other">Levin, E. J., Kondrashov, D. A., Wesenberg, G. E. &amp; Phillips, G. N. (2007). <italic toggle="yes">Structure</italic><bold>15</bold>, 1040–1052.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.str.2007.06.019</pub-id><pub-id pub-id-type="pmcid">PMC2039884</pub-id><pub-id pub-id-type="pmid">17850744</pub-id></mixed-citation></ref><ref id="bb41"><mixed-citation publication-type="other">Liebschner, D., Afonine, P. V., Baker, M. L., Bunkóczi, G., Chen, V. B., Croll, T. I., Hintze, B., Hung, L.-W., Jain, S., McCoy, A. J., Moriarty, N. W., Oeffner, R. D., Poon, B. K., Prisant, M. G., Read, R. J., Richardson, J. S., Richardson, D. C., Sammito, M. D., Sobolev, O. V., Stockwell, D. H., Terwilliger, T. C., Urzhumtsev, A. G., Videau, L. L., Williams, C. J. &amp; Adams, P. D. (2019). <italic toggle="yes">Acta Cryst.</italic> D<bold>75</bold>, 861–877.</mixed-citation></ref><ref id="bb42"><mixed-citation publication-type="other">Liebschner, D., Afonine, P. V., Moriarty, N. W., Poon, B. K., Sobolev, O. V., Terwilliger, T. C. &amp; Adams, P. D. (2017). <italic toggle="yes">Acta Cryst.</italic> D<bold>73</bold>, 148–157.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798316018210</pub-id><pub-id pub-id-type="pmcid">PMC5297918</pub-id><pub-id pub-id-type="pmid">28177311</pub-id></mixed-citation></ref><ref id="bb43"><mixed-citation publication-type="other">Liebschner, D., Dauter, M., Brzuszkiewicz, A. &amp; Dauter, Z. (2013). <italic toggle="yes">Acta Cryst.</italic> D<bold>69</bold>, 1447–1462.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444913009050</pub-id><pub-id pub-id-type="pmcid">PMC3727327</pub-id><pub-id pub-id-type="pmid">23897468</pub-id></mixed-citation></ref><ref id="bb44"><mixed-citation publication-type="other">Lin, Z., Akin, H., Rao, R., Hie, B., Zhu, Z., Lu, W., Smetanin, N., Verkuil, R., Kabeli, O., Shmueli, Y., dos Santos Costa, A., Fazel-Zarandi, M., Sercu, T., Candido, S. &amp; Rives, A. (2023). <italic toggle="yes">Science</italic><bold>379</bold>, 1123–1130.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1126/science.ade2574</pub-id><pub-id pub-id-type="pmid">36927031</pub-id></mixed-citation></ref><ref id="bb45"><mixed-citation publication-type="other">Liu, N., Mikhailovskii, O., Skrynnikov, N. R. &amp; Xue, Y. (2023). <italic toggle="yes">IUCrJ</italic><bold>10</bold>, 16–26.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2052252522011198</pub-id><pub-id pub-id-type="pmcid">PMC9812212</pub-id><pub-id pub-id-type="pmid">36598499</pub-id></mixed-citation></ref><ref id="bb46"><mixed-citation publication-type="other">Loris, R., De Greve, H., Dao-Thi, M.-H., Messens, J., Imberty, A. &amp; Wyns, L. (2000). <italic toggle="yes">J. Mol. Biol.</italic><bold>301</bold>, 987–1002.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1006/jmbi.2000.4016</pub-id><pub-id pub-id-type="pmid">10966800</pub-id></mixed-citation></ref><ref id="bb47"><mixed-citation publication-type="other">Lovell, S. C., Word, J. M., Richardson, J. S. &amp; Richardson, D. C. (2000). <italic toggle="yes">Proteins</italic><bold>40</bold>, 389–408.<pub-id pub-id-type="pmid">10861930</pub-id></mixed-citation></ref><ref id="bb48"><mixed-citation publication-type="other">Luzzati, V. (1952). <italic toggle="yes">Acta Cryst.</italic><bold>5</bold>, 802–810.</mixed-citation></ref><ref id="bb49"><mixed-citation publication-type="other">Ma, P. X., Xue, Y., Coquelle, N., Haller, J. D., Yuwen, T. R., Ayala, I., Mikhailovskii, O., Willbold, D., Colletier, J. P., Skrynnikov, N. R. &amp; Schanda, P. (2015). <italic toggle="yes">Nat. Commun.</italic><bold>6</bold>, 8361.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/ncomms9361</pub-id><pub-id pub-id-type="pmcid">PMC4600728</pub-id><pub-id pub-id-type="pmid">26436197</pub-id></mixed-citation></ref><ref id="bb50"><mixed-citation publication-type="other">MacCallum, J. L., Hua, L., Schnieders, M. J., Pande, V. S., Jacobson, M. P. &amp; Dill, K. A. (2009). <italic toggle="yes">Proteins</italic><bold>77</bold>, 66–80.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.22538</pub-id><pub-id pub-id-type="pmcid">PMC2801025</pub-id><pub-id pub-id-type="pmid">19714776</pub-id></mixed-citation></ref><ref id="bb51"><mixed-citation publication-type="other">Manjasetty, B. A., Quedenau, C., Sievert, V., Büssow, K., Niesen, F., Delbrück, H. &amp; Heinemann, U. (2004). <italic toggle="yes">Proteins</italic><bold>55</bold>, 214–217.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.20028</pub-id><pub-id pub-id-type="pmid">14997555</pub-id></mixed-citation></ref><ref id="bb52"><mixed-citation publication-type="other">Mariani, V., Biasini, M., Barbato, A. &amp; Schwede, T. (2013). <italic toggle="yes">Bioinformatics</italic><bold>29</bold>, 2722–2728.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1093/bioinformatics/btt473</pub-id><pub-id pub-id-type="pmcid">PMC3799472</pub-id><pub-id pub-id-type="pmid">23986568</pub-id></mixed-citation></ref><ref id="bb53"><mixed-citation publication-type="other">McCoy, A. J. (2017). <italic toggle="yes">Protein crystallography. Methods in molecular biology</italic>, Vol. 1607, edited by A. Wlodawer, Z. Dauter &amp; M. Jaskolski. New York: Humana Press. https://doi.org/10.1007/978-1-4939-7000-1_18.</mixed-citation></ref><ref id="bb54"><mixed-citation publication-type="other">McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C. &amp; Read, R. J. (2007). <italic toggle="yes">J. Appl. Cryst.</italic><bold>40</bold>, 658–674.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0021889807021206</pub-id><pub-id pub-id-type="pmcid">PMC2483472</pub-id><pub-id pub-id-type="pmid">19461840</pub-id></mixed-citation></ref><ref id="bb55"><mixed-citation publication-type="other">McCoy, A. J., Sammito, M. D. &amp; Read, R. J. (2022). <italic toggle="yes">Acta Cryst.</italic> D<bold>78</bold>, 1–13.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798321012122</pub-id><pub-id pub-id-type="pmcid">PMC8725160</pub-id><pub-id pub-id-type="pmid">34981757</pub-id></mixed-citation></ref><ref id="bb56"><mixed-citation publication-type="other">McGuffin, L. J., Edmunds, N. S., Genc, A. G., Alharbi, S. M. A., Salehe, B. &amp; Adiyaman, R. (2023). <italic toggle="yes">Nucleic Acids Res.</italic><bold>51</bold>, W274–W280.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1093/nar/gkad297</pub-id><pub-id pub-id-type="pmcid">PMC10320135</pub-id><pub-id pub-id-type="pmid">37102670</pub-id></mixed-citation></ref><ref id="bb57"><mixed-citation publication-type="other">McNicholas, S., Potterton, E., Wilson, K. S. &amp; Noble, M. E. M. (2011). <italic toggle="yes">Acta Cryst.</italic> D<bold>67</bold>, 386–394.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444911007281</pub-id><pub-id pub-id-type="pmcid">PMC3069754</pub-id><pub-id pub-id-type="pmid">21460457</pub-id></mixed-citation></ref><ref id="bb58"><mixed-citation publication-type="other">Millán, C., Keegan, R. M., Pereira, J., Sammito, M. D., Simpkin, A. J., McCoy, A. J., Lupas, A. N., Hartmann, M. D., Rigden, D. J. &amp; Read, R. J. (2021). <italic toggle="yes">Proteins</italic><bold>89</bold>, 1752–1769.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.26214</pub-id><pub-id pub-id-type="pmcid">PMC8881082</pub-id><pub-id pub-id-type="pmid">34387010</pub-id></mixed-citation></ref><ref id="bb59"><mixed-citation publication-type="other">Murshudov, G. N., Vagin, A. A. &amp; Dodson, E. J. (1997). <italic toggle="yes">Acta Cryst.</italic> D<bold>53</bold>, 240–255.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444996012255</pub-id><pub-id pub-id-type="pmid">15299926</pub-id></mixed-citation></ref><ref id="bb60"><mixed-citation publication-type="other">Oeffner, R. D., Bunkóczi, G., McCoy, A. J. &amp; Read, R. J. (2013). <italic toggle="yes">Acta Cryst.</italic> D<bold>69</bold>, 2209–2215.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444913023512</pub-id><pub-id pub-id-type="pmcid">PMC3817694</pub-id><pub-id pub-id-type="pmid">24189232</pub-id></mixed-citation></ref><ref id="bb61"><mixed-citation publication-type="other">Oeffner, R. D., Croll, T. I., Millán, C., Poon, B. K., Schlicksup, C. J., Read, R. J. &amp; Terwilliger, T. C. (2022). <italic toggle="yes">Acta Cryst.</italic> D<bold>78</bold>, 1303–1314.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798322010026</pub-id><pub-id pub-id-type="pmcid">PMC9629492</pub-id><pub-id pub-id-type="pmid">36322415</pub-id></mixed-citation></ref><ref id="bb62"><mixed-citation publication-type="other">Ohlendorf, D. H. (1994). <italic toggle="yes">Acta Cryst.</italic> D<bold>50</bold>, 808–812.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444994002659</pub-id><pub-id pub-id-type="pmid">15299347</pub-id></mixed-citation></ref><ref id="bb63"><mixed-citation publication-type="other">Olechnovič, K., Monastyrskyy, B., Kryshtafovych, A. &amp; Venclovas, Č. (2019). <italic toggle="yes">Bioinformatics</italic><bold>35</bold>, 937–944.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1093/bioinformatics/bty760</pub-id><pub-id pub-id-type="pmcid">PMC6419896</pub-id><pub-id pub-id-type="pmid">30169622</pub-id></mixed-citation></ref><ref id="bb64"><mixed-citation publication-type="other">Pellegrini, M., Grønbech-Jensen, N., Kelly, J. A., Pfluegl, G. M. &amp; Yeates, T. O. (1997). <italic toggle="yes">Proteins</italic><bold>29</bold>, 426–432.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/(sici)1097-0134(199712)29:4&lt;426::aid-prot3&gt;3.0.co;2-6</pub-id><pub-id pub-id-type="pmid">9408940</pub-id></mixed-citation></ref><ref id="bb65"><mixed-citation publication-type="other">Pereira, J., Simpkin, A. J., Hartmann, M. D., Rigden, D. J., Keegan, R. M. &amp; Lupas, A. N. (2021). <italic toggle="yes">Proteins</italic><bold>89</bold>, 1687–1699.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.26171</pub-id><pub-id pub-id-type="pmid">34218458</pub-id></mixed-citation></ref><ref id="bb910"><mixed-citation publication-type="other">Poon, G. M. K. (2010). <italic toggle="yes">Anal. Biochem.</italic><bold>400</bold>, 229–236. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.ab.2010.01.025</pub-id><pub-id pub-id-type="pmid">20100451</pub-id></mixed-citation></ref><ref id="bb66"><mixed-citation publication-type="other">Qian, B., Raman, S., Das, R., Bradley, P., McCoy, A. J., Read, R. J. &amp; Baker, D. (2007). <italic toggle="yes">Nature</italic><bold>450</bold>, 259–264.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/nature06249</pub-id><pub-id pub-id-type="pmcid">PMC2504711</pub-id><pub-id pub-id-type="pmid">17934447</pub-id></mixed-citation></ref><ref id="bb67"><mixed-citation publication-type="other">Ramage, R., Green, J., Muir, T. W., Ogunjobi, O. M., Love, S. &amp; Shaw, K. (1994). <italic toggle="yes">Biochem. J.</italic><bold>299</bold>, 151–158.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1042/bj2990151</pub-id><pub-id pub-id-type="pmcid">PMC1138034</pub-id><pub-id pub-id-type="pmid">8166633</pub-id></mixed-citation></ref><ref id="bb68"><mixed-citation publication-type="other">Rämisch, S., Lizatović, R. &amp; André, I. (2015). <italic toggle="yes">Acta Cryst.</italic> D<bold>71</bold>, 606–614.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S1399004714028247</pub-id><pub-id pub-id-type="pmid">25760609</pub-id></mixed-citation></ref><ref id="bb69"><mixed-citation publication-type="other">Rapp, C. S. &amp; Pollack, R. M. (2005). <italic toggle="yes">Proteins</italic><bold>60</bold>, 103–109.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.20492</pub-id><pub-id pub-id-type="pmid">15852307</pub-id></mixed-citation></ref><ref id="bb70"><mixed-citation publication-type="other">Read, R. J. (1986). <italic toggle="yes">Acta Cryst.</italic> A<bold>42</bold>, 140–149.</mixed-citation></ref><ref id="bb71"><mixed-citation publication-type="other">Read, R. J. &amp; McCoy, A. J. (2016). <italic toggle="yes">Acta Cryst.</italic> D<bold>72</bold>, 375–387.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798315013236</pub-id><pub-id pub-id-type="pmcid">PMC4784668</pub-id><pub-id pub-id-type="pmid">26960124</pub-id></mixed-citation></ref><ref id="bb72"><mixed-citation publication-type="other">Read, R. J., Sammito, M. D., Kryshtafovych, A. &amp; Croll, T. I. (2019). <italic toggle="yes">Proteins</italic><bold>87</bold>, 1249–1262.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.25794</pub-id><pub-id pub-id-type="pmcid">PMC6851427</pub-id><pub-id pub-id-type="pmid">31365160</pub-id></mixed-citation></ref><ref id="bb73"><mixed-citation publication-type="other">Rice, L. M., Shamoo, Y. &amp; Brünger, A. T. (1998). <italic toggle="yes">J. Appl. Cryst.</italic><bold>31</bold>, 798–805.</mixed-citation></ref><ref id="bb74"><mixed-citation publication-type="other">Rigden, D. J., Keegan, R. M. &amp; Winn, M. D. (2008). <italic toggle="yes">Acta Cryst.</italic> D<bold>64</bold>, 1288–1291.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444908033192</pub-id><pub-id pub-id-type="pmid">19018106</pub-id></mixed-citation></ref><ref id="bb75"><mixed-citation publication-type="other">Šali, A. &amp; Blundell, T. L. (1993). <italic toggle="yes">J. Mol. Biol.</italic><bold>234</bold>, 779–815.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1006/jmbi.1993.1626</pub-id><pub-id pub-id-type="pmid">8254673</pub-id></mixed-citation></ref><ref id="bb76"><mixed-citation publication-type="other">Schormann, N., Symersky, J. &amp; Luo, M. (2004). <italic toggle="yes">Acta Cryst.</italic> D<bold>60</bold>, 1840–1845.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444904017846</pub-id><pub-id pub-id-type="pmid">15388931</pub-id></mixed-citation></ref><ref id="bb77"><mixed-citation publication-type="other">Simpkin, A. J., Thomas, J. M. H., Simkovic, F., Keegan, R. M. &amp; Rigden, D. J. (2019). <italic toggle="yes">Acta Cryst.</italic> D<bold>75</bold>, 1051–1062.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798319013962</pub-id><pub-id pub-id-type="pmcid">PMC6889911</pub-id><pub-id pub-id-type="pmid">31793899</pub-id></mixed-citation></ref><ref id="bb78"><mixed-citation publication-type="other">Stokes-Rees, I. &amp; Sliz, P. (2010). <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>107</bold>, 21476–21481.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1073/pnas.1012095107</pub-id><pub-id pub-id-type="pmcid">PMC3003117</pub-id><pub-id pub-id-type="pmid">21098306</pub-id></mixed-citation></ref><ref id="bb79"><mixed-citation publication-type="other">Suhre, K. &amp; Sanejouand, Y. H. (2004). <italic toggle="yes">Nucleic Acids Res.</italic><bold>32</bold>, W610–W614.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1093/nar/gkh368</pub-id><pub-id pub-id-type="pmcid">PMC441506</pub-id><pub-id pub-id-type="pmid">15215461</pub-id></mixed-citation></ref><ref id="bb80"><mixed-citation publication-type="other">Sun, L., Vella, P., Schnell, R., Polyakova, A., Bourenkov, G., Li, F., Cimdins, A., Schneider, T. R., Lindqvist, Y., Galperin, M. Y., Schneider, G. &amp; Römling, U. (2018). <italic toggle="yes">J. Mol. Biol.</italic><bold>430</bold>, 3170–3189.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/j.jmb.2018.07.008</pub-id><pub-id pub-id-type="pmcid">PMC7020665</pub-id><pub-id pub-id-type="pmid">30017920</pub-id></mixed-citation></ref><ref id="bb81"><mixed-citation publication-type="other">Takekawa, N., Isumi, M., Terashima, H., Zhu, S., Nishino, Y., Sakuma, M., Kojima, S., Homma, M. &amp; Imada, K. (2019). <italic toggle="yes">mBio</italic><bold>10</bold>, e00292–19.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1128/mBio.00292-19</pub-id><pub-id pub-id-type="pmcid">PMC6426602</pub-id><pub-id pub-id-type="pmid">30890608</pub-id></mixed-citation></ref><ref id="bb82"><mixed-citation publication-type="other">Terwilliger, T. C., Afonine, P. V., Liebschner, D., Croll, T. I., McCoy, A. J., Oeffner, R. D., Williams, C. J., Poon, B. K., Richardson, J. S., Read, R. J. &amp; Adams, P. D. (2023). <italic toggle="yes">Acta Cryst.</italic> D<bold>79</bold>, 234–244.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S205979832300102X</pub-id><pub-id pub-id-type="pmcid">PMC9986801</pub-id><pub-id pub-id-type="pmid">36876433</pub-id></mixed-citation></ref><ref id="bb83"><mixed-citation publication-type="other">Terwilliger, T. C., Grosse-Kunstleve, R. W., Afonine, P. V., Adams, P. D., Moriarty, N. W., Zwart, P., Read, R. J., Turk, D. &amp; Hung, L.-W. (2007). <italic toggle="yes">Acta Cryst.</italic> D<bold>63</bold>, 597–610.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444907009791</pub-id><pub-id pub-id-type="pmcid">PMC2483474</pub-id><pub-id pub-id-type="pmid">17452785</pub-id></mixed-citation></ref><ref id="bb84"><mixed-citation publication-type="other">Tian, C., Kasavajhala, K., Belfon, K. A. A., Raguette, L., Huang, H., Migues, A. N., Bickel, J., Wang, Y., Pincay, J., Wu, Q. &amp; Simmerling, C. (2020). <italic toggle="yes">J. Chem. Theory Comput.</italic><bold>16</bold>, 528–552.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1021/acs.jctc.9b00591</pub-id><pub-id pub-id-type="pmid">31714766</pub-id></mixed-citation></ref><ref id="bb85"><mixed-citation publication-type="other">van den Bedem, H., Dhanik, A., Latombe, J.-C. &amp; Deacon, A. M. (2009). <italic toggle="yes">Acta Cryst.</italic> D<bold>65</bold>, 1107–1117.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444909030613</pub-id><pub-id pub-id-type="pmcid">PMC2756169</pub-id><pub-id pub-id-type="pmid">19770508</pub-id></mixed-citation></ref><ref id="bb86"><mixed-citation publication-type="other">Vijay-Kumar, S., Bugg, C. E. &amp; Cook, W. J. (1987). <italic toggle="yes">J. Mol. Biol.</italic><bold>194</bold>, 531–544.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1016/0022-2836(87)90679-6</pub-id><pub-id pub-id-type="pmid">3041007</pub-id></mixed-citation></ref><ref id="bb911"><mixed-citation publication-type="other">Vonrhein, C., Flensburg, C., Keller, P., Sharff, A., Smart, O., Paciorek, W., Womack, T. &amp; Bricogne, G. (2011). <italic toggle="yes">Acta Cryst.</italic> D<bold>67</bold>, 293–302. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S0907444911007773</pub-id><pub-id pub-id-type="pmcid">PMC3069744</pub-id><pub-id pub-id-type="pmid">21460447</pub-id></mixed-citation></ref><ref id="bb87"><mixed-citation publication-type="other">Wang, W., Gong, Z. &amp; Hendrickson, W. A. (2025). <italic toggle="yes">Acta Cryst.</italic> D<bold>81</bold>, 4–21.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1107/S2059798324011999</pub-id><pub-id pub-id-type="pmcid">PMC11740581</pub-id><pub-id pub-id-type="pmid">39711199</pub-id></mixed-citation></ref><ref id="bb88"><mixed-citation publication-type="other">Watson, J. L., Juergens, D., Bennett, N. R., Trippe, B. L., Yim, J., Eisenach, H. E., Ahern, W., Borst, A. J., Ragotte, R. J., Milles, L. F., Wicky, B. I. M., Hanikel, N., Pellock, S. J., Courbet, A., Sheffler, W., Wang, J., Venkatesh, P., Sappington, I., Torres, S. V., Lauko, A., De Bortoli, V., Mathieu, E., Ovchinnikov, S., Barzilay, R., Jaakkola, T. S., DiMaio, F., Baek, M. &amp; Baker, D. (2023). <italic toggle="yes">Nature</italic><bold>620</bold>, 1089–1100.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1038/s41586-023-06415-8</pub-id><pub-id pub-id-type="pmcid">PMC10468394</pub-id><pub-id pub-id-type="pmid">37433327</pub-id></mixed-citation></ref><ref id="bb912"><mixed-citation publication-type="other">Webb, B. &amp; Sali, A. (2016). <italic toggle="yes">Curr. Protoc. Bioinform.</italic><bold>54</bold>, 5. <pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/cpbi.3</pub-id><pub-id pub-id-type="pmcid">PMC5031415</pub-id><pub-id pub-id-type="pmid">27322406</pub-id></mixed-citation></ref><ref id="bb89"><mixed-citation publication-type="other">Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., Jain, S., Lewis, S. M., Arendall, W. B., Snoeyink, J., Adams, P. D., Lovell, S. C., Richardson, J. S. &amp; Richardson, D. C. (2018). <italic toggle="yes">Protein Sci.</italic><bold>27</bold>, 293–315.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/pro.3330</pub-id><pub-id pub-id-type="pmcid">PMC5734394</pub-id><pub-id pub-id-type="pmid">29067766</pub-id></mixed-citation></ref><ref id="bb90"><mixed-citation publication-type="other">Yang, J., Anishchenko, I., Park, H., Peng, Z., Ovchinnikov, S. &amp; Baker, D. (2020). <italic toggle="yes">Proc. Natl Acad. Sci. USA</italic><bold>117</bold>, 1496–1503.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1073/pnas.1914677117</pub-id><pub-id pub-id-type="pmcid">PMC6983395</pub-id><pub-id pub-id-type="pmid">31896580</pub-id></mixed-citation></ref><ref id="bb91"><mixed-citation publication-type="other">Zheng, W., Li, Y., Zhang, C., Zhou, X., Pearce, R., Bell, E. W., Huang, X. &amp; Zhang, Y. (2021). <italic toggle="yes">Proteins</italic><bold>89</bold>, 1734–1751.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.26193</pub-id><pub-id pub-id-type="pmcid">PMC8616857</pub-id><pub-id pub-id-type="pmid">34331351</pub-id></mixed-citation></ref><ref id="bb92"><mixed-citation publication-type="other">Zheng, W., Wuyun, Q., Freddolino, L. &amp; Zhang, Y. (2023). <italic toggle="yes">Proteins</italic><bold>91</bold>, 1684–1703.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1002/prot.26585</pub-id><pub-id pub-id-type="pmcid">PMC10840719</pub-id><pub-id pub-id-type="pmid">37650367</pub-id></mixed-citation></ref><ref id="bb93"><mixed-citation publication-type="other">Zoete, V., Michielin, O. &amp; Karplus, M. (2002). <italic toggle="yes">J. Mol. Biol.</italic><bold>315</bold>, 21–52.<pub-id assigning-authority="pmc" pub-id-type="doi">10.1006/jmbi.2001.5173</pub-id><pub-id pub-id-type="pmid">11771964</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>MR models and their corresponding structures for the small antiviral protein LCB2. (<italic toggle="yes">a</italic>)–(<italic toggle="yes">f</italic>) Superposition of the final structures (red) and their parent MR models (blue, annotated at the top of the panels). The structures are superimposed via C<sup>α</sup> atoms from the first and second helices (residues 6–22 and 25–41). (<italic toggle="yes">g</italic>) Intermolecular hydrogen bond between residues Asn43 and Glu46 in the structure derived from the <italic toggle="yes">AlphaFold3</italic> model (for visual clarity, we do not show the symmetry-equivalent hydrogen bond). (<italic toggle="yes">h</italic>) Superposition of the six crystallographic structures colored according to their parent MR models: blue (<italic toggle="yes">AlphaFold3</italic>), magenta (<italic toggle="yes">AlphaFold2</italic>), green (<italic toggle="yes">MultiFOLD</italic>), turquoise (<italic toggle="yes">Rosetta</italic>), red (<italic toggle="yes">RoseTTAFold</italic>) and orange (<italic toggle="yes">trRosetta</italic>). The structures are superimposed via C<sup>α</sup> atoms from the consensus set. (<italic toggle="yes">i</italic>) Superposition of the six crystallographic structures with side chains colored according to their parent MR models. The structures are superimposed via C<sup>α</sup> atoms from the consensus set, as in panel (<italic toggle="yes">h</italic>). The figures were prepared using the program <italic toggle="yes">CCP4MG</italic> (McNicholas <italic toggle="yes">et al.</italic>, 2011<xref ref-type="bibr" rid="bb57"> ▸</xref>).</p></caption><graphic orientation="portrait" position="float" xlink:href="m-12-00488-fig1.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Pairwise RMSD for six computer-predicted MR models and six respective fully refined structures of LCB2. The RMSD values were calculated for all non-hydrogen atoms in the ‘consensus set’ (shared by all models/structures, see <italic toggle="yes">Materials and methods</italic><xref ref-type="sec" rid="sec2"/>).</p></caption><graphic orientation="portrait" position="float" xlink:href="m-12-00488-fig2.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Principal component map PC1–PC2 for six MR models and six refined structures of LCB2 (solid and open circles, respectively). The structural states used in the PCA are vectors composed of the non-hydrogen atom coordinates from within the consensus region (see the supporting information for details).</p></caption><graphic orientation="portrait" position="float" xlink:href="m-12-00488-fig3.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Side chain of residue Glu53 in the six final structures of LCB2. Electron density maps 2<italic toggle="yes">mF</italic><sub>o</sub> − <italic toggle="yes">DF</italic><sub>c</sub> are plotted at the level of 1σ (the differential maps <italic toggle="yes">mF</italic><sub>o</sub> − <italic toggle="yes">DF</italic><sub>c</sub> are not plotted since they show no observable density at the default level of 3σ). The color scheme is the same as in Fig. 1<xref ref-type="fig" rid="fig1"> ▸</xref>. In addition to Glu53, some other surface side chains in LCB2 also show conformational disorder, see Fig. S3 and Fig. S4.</p></caption><graphic orientation="portrait" position="float" xlink:href="m-12-00488-fig4.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Side chain of residue Glu53 in the five specially prepared models of LCB2. The models represent the fully refined structure <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link>, where the Glu53 side chain has been placed in pm0°, tm-20°, pt<underline>-20°</underline>, tp10° and mp0° conformations (as indicated in the plot). Electron density maps 2<italic toggle="yes">mF</italic><sub>o</sub> − <italic toggle="yes">DF</italic><sub>c</sub> are plotted at the level of 1σ (blue mesh) and the differential maps <italic toggle="yes">mF</italic><sub>o</sub> − <italic toggle="yes">DF</italic><sub>c</sub> are plotted at the level of 3σ (green/red mesh). The tm-20° model can be further refined, improving the agreement with its associated electron density (not shown).</p></caption><graphic orientation="portrait" position="float" xlink:href="m-12-00488-fig5.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Conformational preferences of the Glu53 side chain in LCB2. (<italic toggle="yes">a</italic>) Crystallography-derived conformations from Fig. 4<xref ref-type="fig" rid="fig4"> ▸</xref> (red asterisks) and Fig. 5<xref ref-type="fig" rid="fig5"> ▸</xref> (tm-20°, red circle). Also indicated are canonical rotameric states of the Glu side chain (crosses) and their nomenclature (Lovell <italic toggle="yes">et al.</italic>, 2000<xref ref-type="bibr" rid="bb47"> ▸</xref>). (<italic toggle="yes">b</italic>) Heat map showing (χ<sub>1</sub>, χ<sub>2</sub>) probability density distribution according to the MD simulation of the LCB2 crystal. The trajectory was started from the UC coordinates based on the structure <ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link> (descendent from the <italic toggle="yes">AlphaFold3</italic> model). For better visualization, the range of χ<sub>1</sub> and χ<sub>2</sub> is taken to be [0–360°]. The canonical rotameric states are indicated by crosses, as in panel (<italic toggle="yes">a</italic>).</p></caption><graphic orientation="portrait" position="float" xlink:href="m-12-00488-fig6.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Protein structure calculation leads to a range of very similar, but distinct, structures, corresponding to the (roughly equiprobable) local minima in the objective function. Initial MR models and final (fully refined) structures are represented by solid and open circles, respectively.</p></caption><graphic orientation="portrait" position="float" xlink:href="m-12-00488-fig7.jpg" xmlns:xlink="http://www.w3.org/1999/xlink"/></fig><table-wrap id="table1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Potential MR models for the mini-protein LCB2 obtained from different structure predictors and their <italic toggle="yes">Phaser</italic>-determined LLG and TFZ scores</title><p>The PDB was accessed on 30 April 2025.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">Model</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom"><italic toggle="yes">Phaser</italic> LLG score</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom"><italic toggle="yes">Phaser</italic> TFZ score</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">No. of MR models in the PDB<xref ref-type="table-fn" rid="tfn1">†</xref></th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">First use as an MR model in the PDB<xref ref-type="table-fn" rid="tfn2">‡</xref></th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">AlphaFold3</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">213</td><td align="left" colspan="1" rowspan="1" valign="top">16</td><td align="left" colspan="1" rowspan="2" valign="middle">2142<xref ref-type="table-fn" rid="tfn3">§</xref></td><td align="left" colspan="1" rowspan="2" valign="middle">2021</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">AlphaFold2</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">208</td><td align="left" colspan="1" rowspan="1" valign="top">17</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">MultiFOLD</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">176</td><td align="left" colspan="1" rowspan="1" valign="top">15</td><td align="left" colspan="1" rowspan="1" valign="top">0</td><td align="left" colspan="1" rowspan="1" valign="top">—</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">Rosetta</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">105</td><td align="left" colspan="1" rowspan="1" valign="top">12</td><td align="left" colspan="1" rowspan="1" valign="top">71</td><td align="left" colspan="1" rowspan="1" valign="top">2007</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">RoseTTAFold</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">94</td><td align="left" colspan="1" rowspan="1" valign="top">11</td><td align="left" colspan="1" rowspan="1" valign="top">46</td><td align="left" colspan="1" rowspan="1" valign="top">2021</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">trRosetta</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">87</td><td align="left" colspan="1" rowspan="1" valign="top">10</td><td align="left" colspan="1" rowspan="1" valign="top">2</td><td align="left" colspan="1" rowspan="1" valign="top">2021</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">QUARK</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">88</td><td align="left" colspan="1" rowspan="1" valign="top">5</td><td align="left" colspan="1" rowspan="1" valign="top">2</td><td align="left" colspan="1" rowspan="1" valign="top">2018</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">Phyre2</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">82</td><td align="left" colspan="1" rowspan="1" valign="top">5</td><td align="left" colspan="1" rowspan="1" valign="top">32<xref ref-type="table-fn" rid="tfn4">¶</xref></td><td align="left" colspan="1" rowspan="1" valign="top">2005</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">I-TASSER</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">57</td><td align="left" colspan="1" rowspan="1" valign="top">5</td><td align="left" colspan="1" rowspan="1" valign="top">19</td><td align="left" colspan="1" rowspan="1" valign="top">2011</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">
<italic toggle="yes">SWISS-MODEL</italic>
</td><td align="left" colspan="1" rowspan="1" valign="top">25</td><td align="left" colspan="1" rowspan="1" valign="top">5</td><td align="left" colspan="1" rowspan="1" valign="top">170</td><td align="left" colspan="1" rowspan="1" valign="top">1999</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>†</label><p>The number of identifiable PDB structures solved by using MR models from a given predictor.</p></fn><fn id="tfn2"><label>‡</label><p>The release date of the earliest such PDB structure.</p></fn><fn id="tfn3"><label>§</label><p>Probably includes a small number of models from the older program <italic toggle="yes">AlphaFold</italic>.</p></fn><fn id="tfn4"><label>¶</label><p>Probably includes a small number of models from the older program <italic toggle="yes">Phyre</italic>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Refinement statistics for LCB2 structures solved using different computer-predicted MR models</title></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" colspan="1" rowspan="1" valign="bottom"> </th><th align="left" colspan="6" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">Predictor</th></tr><tr><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom"> </th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">
<italic toggle="yes">AlphaFold3</italic>
</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">
<italic toggle="yes">AlphaFold2</italic>
</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">
<italic toggle="yes">MultiFOLD</italic>
</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">
<italic toggle="yes">Rosetta</italic>
</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">
<italic toggle="yes">RoseTTAFold</italic>
</th><th align="left" colspan="1" rowspan="1" style="border-bottom:1px solid black;" valign="bottom">
<italic toggle="yes">trRosetta</italic>
</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic toggle="yes">R</italic><sub>work</sub>/<italic toggle="yes">R</italic><sub>free</sub></td><td align="left" colspan="1" rowspan="1" valign="top">0.209/0.249</td><td align="left" colspan="1" rowspan="1" valign="top">0.212/0.240</td><td align="left" colspan="1" rowspan="1" valign="top">0.214/0.252</td><td align="left" colspan="1" rowspan="1" valign="top">0.214/0.245</td><td align="left" colspan="1" rowspan="1" valign="top">0.208/0.240</td><td align="left" colspan="1" rowspan="1" valign="top">0.211/0.254</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"><italic toggle="yes">MolProbity</italic> score (percentile)</td><td align="left" colspan="1" rowspan="1" valign="top">0.50 (100)</td><td align="left" colspan="1" rowspan="1" valign="top">0.50 (100)</td><td align="left" colspan="1" rowspan="1" valign="top">0.98 (100)</td><td align="left" colspan="1" rowspan="1" valign="top">0.98 (100)</td><td align="left" colspan="1" rowspan="1" valign="top">0.80 (100)</td><td align="left" colspan="1" rowspan="1" valign="top">0.80 (100)</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Ramachandran</td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Favored (%)</td><td align="left" colspan="1" rowspan="1" valign="top">98</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">98</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">98</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Allowed (%)</td><td align="left" colspan="1" rowspan="1" valign="top">2</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top"> 2</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">2</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Outliers (%)</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Side chains</td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Rotameric (%)</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">100</td><td align="left" colspan="1" rowspan="1" valign="top">100</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Outliers (%)</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Clash score</td><td align="left" colspan="1" rowspan="1" valign="top">0.00</td><td align="left" colspan="1" rowspan="1" valign="top">0.00</td><td align="left" colspan="1" rowspan="1" valign="top">2.06</td><td align="left" colspan="1" rowspan="1" valign="top">2.06</td><td align="left" colspan="1" rowspan="1" valign="top">1.02</td><td align="left" colspan="1" rowspan="1" valign="top">1.02</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">RMS deviations</td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Bond lengths (Å)</td><td align="left" colspan="1" rowspan="1" valign="top">0.002</td><td align="left" colspan="1" rowspan="1" valign="top">0.002</td><td align="left" colspan="1" rowspan="1" valign="top">0.002</td><td align="left" colspan="1" rowspan="1" valign="top">0.002</td><td align="left" colspan="1" rowspan="1" valign="top">0.002 </td><td align="left" colspan="1" rowspan="1" valign="top">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Angles (°)</td><td align="left" colspan="1" rowspan="1" valign="top">0.36</td><td align="left" colspan="1" rowspan="1" valign="top">0.38</td><td align="left" colspan="1" rowspan="1" valign="top">0.40</td><td align="left" colspan="1" rowspan="1" valign="top">0.40</td><td align="left" colspan="1" rowspan="1" valign="top">0.38</td><td align="left" colspan="1" rowspan="1" valign="top">0.36</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">No. of atoms</td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Protein</td><td align="left" colspan="1" rowspan="1" valign="top">469</td><td align="left" colspan="1" rowspan="1" valign="top">469</td><td align="left" colspan="1" rowspan="1" valign="top">469</td><td align="left" colspan="1" rowspan="1" valign="top">469</td><td align="left" colspan="1" rowspan="1" valign="top">469</td><td align="left" colspan="1" rowspan="1" valign="top">469</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Water</td><td align="left" colspan="1" rowspan="1" valign="top">18</td><td align="left" colspan="1" rowspan="1" valign="top">18</td><td align="left" colspan="1" rowspan="1" valign="top">18</td><td align="left" colspan="1" rowspan="1" valign="top">20</td><td align="left" colspan="1" rowspan="1" valign="top">18</td><td align="left" colspan="1" rowspan="1" valign="top">24</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Co-solvent (glycerol)</td><td align="left" colspan="1" rowspan="1" valign="top">24</td><td align="left" colspan="1" rowspan="1" valign="top">6</td><td align="left" colspan="1" rowspan="1" valign="top">12</td><td align="left" colspan="1" rowspan="1" valign="top">12</td><td align="left" colspan="1" rowspan="1" valign="top">18</td><td align="left" colspan="1" rowspan="1" valign="top">18</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">Average <italic toggle="yes">B</italic> (Å<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1" valign="top">14</td><td align="left" colspan="1" rowspan="1" valign="top">13</td><td align="left" colspan="1" rowspan="1" valign="top">12</td><td align="left" colspan="1" rowspan="1" valign="top">13</td><td align="left" colspan="1" rowspan="1" valign="top">12</td><td align="left" colspan="1" rowspan="1" valign="top">12</td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td><td align="left" colspan="1" rowspan="1" valign="top"> </td></tr><tr><td align="left" colspan="1" rowspan="1" valign="top">PDB deposition</td><td align="left" colspan="1" rowspan="1" valign="top">
<ext-link ext-link-type="uri" xlink:href="https://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&amp;pdbId=8c3e" xmlns:xlink="http://www.w3.org/1999/xlink">8c3e</ext-link>
</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td><td align="left" colspan="1" rowspan="1" valign="top">—</td></tr></tbody></table></table-wrap></floats-group></article>